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(57) ABSTRACT 
Microneedle devices and methods of use thereof are pro-
vided for the enhanced transport of molecules, including 
drugs and biological molecules, across tissue by improving 
the interaction of microneedles and a deformable, elastic 
biological barrier, such as human skin. The devices and 
methods act to (1) limit the elasticity, (2) adapt to the 
elasticity, (3) utilize alternate ways of creating the holes for 
the microneedles to penetrate the biological barrier, other 
than the simply direct pressure of the microneedle substrate 
to the barrier surface, or ( 4) any combination of these 
methods. In preferred embodiments for limiting the elastic-
ity of skin, the microneedle device includes features suitable 
for stretching, pulling, or pinching the skin to present a more 
rigid, less deformable, surface in the area to which the 
microneedles are applied (i.e. penetrate). In a preferred 
embodiments for adapting the device to the elasticity of skin, 
the device comprising one or more extensions interposed 
between the substrate and the base end of at least a portion 
of the microneedles. 
19 Claims, 15 Drawing Sheets 
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DEVICES AND METHODS FOR ENHANCED 
MICRONEEDLE PENETRATION OF 
BIOLOGICAL BARRIERS 
2 
For example, U.S. Pat. No. 5,879,326 to Godshall et al. 
and PCT WO 96/37256 by Silicon Microdevices, Inc. dis-
close a transdermal drug delivery apparatus that includes a 
cutter portion having a plurality of microprotrusions, which 
BACKGROUND OF THE INVENTION 
This invention is generally in the field of devices for the 
transport of therapeutic or biological molecules across tissue 
barriers, such as for drug delivery or sampling of biological 
fluids. 
5 have straight sidewalls, extending from a substrate that is in 
communication with a drug reservoir. In operation, the 
microprotrusions penetrate the skin until limited by a stop 
region of the substrate and then are moved parallel to the 
skin to create incisions. Channels in the substrate adjacent to 
10 the microprotrusions allow drug from the reservoir to flow 
to the skin near the area disrupted by the microprotrusions. 
Merely creating a wound, rather than using a needle which 
conveys drug through an enclosed channel into the site of 
Numerous drugs and therapeutic agents have been devel-
oped in the battle against disease and illness. However, a 
frequent limitation of these drugs is their delivery: how to 
transport drugs across biological barriers in the body (e.g., 
the skin, the oral mucosa, the blood-brain barrier), which 15 
normally do not transport drugs at rates that are therapeu-
tically useful or optimal. 
administration, creates variability in dosage. 
U.S. Pat. No. 5,250,023 to Lee et al. discloses a trans-
dermal drug delivery device, which includes a plurality of 
needles having a diameter in the range of 50 to 400 µm. The 
needles are supported in a water-swellable polymer substrate 
through which a drug solution permeates to contact the 
Drugs are commonly administered orally as pills or 
capsules. However, many drugs cannot be effectively deliv-
ered in this manner, due to degradation in the gastrointestinal 
tract and/or elimination by the liver. Moreover, some drugs 
cannot effectively diffuse across the intestinal mucosa. 
Patient compliance may also be a problem, for example, in 
therapies requiring that pills be taken at particular intervals 
over a prolonged time. 
20 surface of the skin. An electric current is applied to the 
device to open the pathways created by the needles, follow-
ing their withdrawal from the skin upon swelling of the 
polymer substrate. 
PCT WO 93/17754 by Gross et al discloses another 
25 transdermal drug delivery device that includes a housing 
having a liquid drug reservoir and a plurality of tubular 
elements for transporting liquid drug into the skin. The 
tubular elements may be in the form of hollow needles 
having inner diameters of less than 1 mm and an outer 
Another common technique for delivering drugs across a 
biological barrier is the use of a needle, such as those used 
with standard syringes or catheters, to transport drugs across 
(through) the skin. While effective for this purpose, needles 
generally cause pain; local damage to the skin at the site of 
insertion; bleeding, which increases the risk of disease 
transmission; and a wound sufficiently large to be a site of 
infection. The withdrawal of bodily fluids, such as for 
diagnostic purposes, using a conventional needle has these 35 
same disadvantages. Needle techniques also generally 
require administration by one trained in its use. The needle 
technique also is undesirable for long term, controlled 
continuous drug delivery. 
30 diameter of 1.0 mm. 
Similarly, current methods of sampling biological fluids 40 
are invasive and suffer from the same disadvantages. For 
example, needles are not preferred for frequent routine use, 
such as sampling of a diabetic's blood glucose or delivery of 
insulin, due to the vascular damage caused by repeated 
punctures. No alternative methodologies are currently in 45 
use. Proposed alternatives to the needle require the use of 
lasers or heat to create a hole in the skin, which is 
inconvenient, expensive, or undesirable for repeated use. 
An alternative delivery technique is the transdermal 
patch, which usually relies on diffusion of the drug across 50 
the skin. However, this method is not useful for many drugs, 
due to the poor permeability (i.e. effective barrier properties) 
of the skin. The rate of diffusion depends in part on the size 
and hydrophilicity of the drug molecules and the concen-
tration gradient across the stratum corneum. Few drugs have 55 
the necessary physiochemical properties to be effectively 
delivered through the skin by passive diffusion. 
Iontophoresis, electroporation, ultrasound, and heat (so-
called active systems) have been used in an attempt to 
improve the rate of delivery. While providing varying 60 
degrees of enhancement, these techniques are not suitable 
for all types of drugs, failing to provide the desired level of 
delivery. In some cases, they are also painful and inconve-
nient or impractical for continuous controlled drug delivery 
over a period of hours or days. Attempts have been made to 65 
design alternative devices for active transfer of drugs, or 
analyte to be measured, through the skin. 
While each of these devices has potential use, there 
remains a need for better drug delivery devices, which make 
smaller incisions, deliver drug with greater efficiency 
(greater drug delivery per quantity applied) and less vari-
ability of drug administration, and/or are easier to use. In 
view of these needs, microneedle devices have been 
developed, which are described in U.S. Ser. Nos. 09/095, 
221, filed Jun. 10, 1998, and 09/316,229, filed May 21, 1999, 
both by Prausnitz et al., which are hereby incorporated by 
reference. Certain embodiments of the device were found to 
readily penetrate skin samples in in vitro experiments, but 
not always provide uniform or complete insertion of the 
microneedles into some areas of the skin in vivo, as the 
stratum corneum and underlying tissues are highly deform-
able and elastic over much of the body. 
It is therefore an object of the present invention to provide 
methods and devices for improving the control of micron-
eedle insertion into the body of a patient. 
It is another object of the present invention to provide a 
microneedle device producing improved microneedle inser-
tion for relatively painless, controlled, safe, convenient 
transdermal delivery of drugs. 
It is a further object of the present invention to provide a 
microneedle device producing improved microneedle inser-
tion for controlled sampling of biological fluids in a 
minimally-invasive, painless, and convenient manner. 
SUMMARY OF THE INVENTION 
Microneedle devices and methods of use thereof are 
provided for the enhanced transport of molecules, including 
drugs and biological molecules, across tissue by improving 
the interaction of an array of micro needles and a deformable, 
elastic biological barrier, such as human skin. The devices 
and methods act to (1) limit the elasticity, (2) adapt to the 
elasticity, (3) utilize alternate ways of creating the holes for 
the microneedles to penetrate the biological barrier, other 
US 6,743,211 Bl 
3 
than the simply direct pressure of the microneedle substrate 
to the barrier surface, or ( 4) any combination of these 
methods. 
4 
FIGS. 12a-c are cross-sectional views illustrating pre-
ferred microneedle devices inserted into skin with altered 
elasticity. 
FIGS. 13a-c are cross-sectional views illustrating pre-
ferred embodiments of micro needle devices which can apply 
suction to skin at the site of insertion. 
FIGS. 14a-c are cross-sectional (14a-b) and perspective 
(14c) views illustrating preferred embodiments of micron-
eedle devices which stretch the skin at the site of insertion. 
FIGS. 15a-c are cross-sectional views illustrating 
examples of micro needle devices which pinch the skin at the 
site of insertion. 
In preferred embodiments for limiting the elasticity of 
skin, the microneedle device includes features suitable for 5 
stretching, pulling, or pinching the skin to present a more 
rigid, less deformable, surface in the area to which the 
microneedles are applied (i.e. penetrate). For example, a 
vacuum can be applied to the area of the skin at the site of 
microneedle application to pull it taut and/or pull the skin 10 
onto the tips of the microneedles. Alternatively or in 
addition, the elasticity of skin can be reduced by applying a 
thin film or membrane over the skin surface at the site of 
application, so as to keep the skin tight, limiting the ability FIG. 16 is a cross-sectional view of a preferred embodi-
15 ment of a microneedle device for use in localized heating of 
skin. 
of the skin to stretch at the application site. The micron-
eedles are then pushed through the film or membrane and 
into the skin. 
In preferred embodiments for adapting the device to the 
elasticity of skin, the microneedles of the device include 
individual extensions or are provided in a curved three 20 
dimensional array, for example, by using a flexible substrate 
and/or varying the height of the micro needles in the array. In 
another embodiment, the microneedles are applied to the 
skin surface at an increased velocity, thereby reducing the 
time available for the stratum corneum and underlying 25 
tissues to deform from contact with the tips or entire length 
of the microneedles. 
In a preferred embodiment for creating holes in the skin 
for microneedles, tiny holes are burned into the skin, for 
example, by heating of the tips of the microneedles and/or 30 
by using a laser. In another embodiment, a focused blast of 
high pressure gas is used to create the holes. 
Essentially all of the microneedle devices and methods 
described herein can be adapted to vibrate the microneedles 
and/or the skin to further enhance penetration. In a preferred 35 
embodiment, the microneedles include a lubricating material 
coated onto or incorporated into the microneedles. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. la-e are side cross-sectional views of a method for 40 
making hollow microneedles. 
FIGS. 2a-g are side cross-sectional views of a method for 
making a hollow microneedle. 
FIGS. 3a-d are side cross-sectional views illustrating a 
preferred method for making hollow microneedles. 
FIGS. 4a-d are side cross-sectional views illustrating a 
preferred method for making hollow silicon microtubes. 
45 
FIGS. 5a-e are side cross-sectional views illustrating a 
preferred method for making hollow metal microtubes. 
50 
FIGS. 6a-d are side cross-sectional views illustrating a 
preferred method for making tapered metal microneedles. 
FIG. 17 is a cross-sectional view of a preferred embodi-
ment of a microneedle device having a microneedle rein-
forcing layer. 
FIGS. 18a-b are cross-sectional views of a preferred 
embodiment of a microneedle device having a flexible 
substrate in an unactivated position (18a) and an activated 
position (18b ). 
FIG. 19 is a cross-sectional view a preferred embodiment 
of a microneedle device having arrays of microneedles with 
spaces between the arrays. 
DETAILED DESCRIPTION OF THE 
INVENTION 
1. Biological Barriers 
The devices disclosed herein are useful in transport of 
material into or across biological barriers including the skin 
(or parts thereof); the blood-brain barrier; mucosal tissue 
(e.g., oral, nasal, ocular, vaginal, urethral, gastrointestinal, 
respiratory); blood vessels; lymphatic vessels; or cell mem-
branes (e.g., for the introduction of material into the interior 
of a cell or cells). The biological barriers can be in humans 
or other types of animals, as well as in plants, insects, or 
other organisms, including bacteria, yeast, fungi, and 
embryos. The microneedle devices can be applied to tissue 
internally with the aid of a catheter or laparoscope. For 
certain applications, such as for drug delivery to an internal 
tissue, the devices can be surgically implanted. 
In a preferred embodiment, the microneedle device dis-
closed herein is applied to skin. The stratum corneum is the 
outer layer, generally between 10 and 50 cells, or between 10 
and 20 µm thick. Unlike other tissue in the body, the stratum 
corneum contains "cells" (called keratinocytes) filled with 
bundles of cross-linked keratin and keratohyalin surrounded 
by an extracellular matrix of lipids. It is this structure that is 
believed to give skin its barrier properties, which prevents 
therapeutic transdermal administration of many drugs. 
Below the stratum corneum is the viable epidermis, which is 
FIGS. 7a-d are side cross-sectional views illustrating a 
method for making tapered microneedles using laser-formed 
molds. 
FIGS. Sa-f are side cross-sectional views illustrating a 
second method for making tapered microneedles using laser-
formed molds. 
55 between 50 and 100 µm thick. The viable epidermis contains 
no blood vessels, and it exchanges metabolites by diffusion 
to and from the dermis. Beneath the viable epidermis is the 
dermis, which is between 1 and 3 mm thick and contains 
FIG. 9 is a side elevational view of a schematic of an 
embodiment of the microneedle device inserted into unde- 60 
formed skin. 
FIGS. lOa-d are illustrations of microneedle devices 
having various embodiments of microneedle extensions. 
FIGS. lla-c are cross-sectional views illustrating micron-
eedle devices having curved substrates (lla), varying 65 
microneedle height (llb), and linear microneedle arrays 
(llc). 
blood vessels, lymphatics, and nerves. 
As used herein, references to using the microneedle 
devices on "skin" also include using the microneedle 
devices with other biological barriers unless expressly lim-
ited to only skin. 
2. The Microneedle Device 
The microneedle devices disclosed herein include a sub-
strate; one or more microneedles; and, optionally, a reservoir 
US 6,743,211 Bl 
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for delivery of drugs or collection of analyte, as well as 
pump(s), sensor(s), and/or microprocessor(s) to control the 
interaction of the foregoing. The microneedle device pref-
erably includes penetration enhancing features to alter or 
adapt to deformable and elastic biological barriers, such as 5 
the skin over much of the human body. 
interconnected to permit passage of fluid and/or solid mate-
rials through the microneedle. As used herein, the term 
"hollow" means having one or more substantially annular 
bores or channels through the interior of the microneedle 
structure, having a diameter sufficiently large to permit 
passage of fluid and/or solid materials through the micron-
a. Substrate 
The substrate of the device can be constructed from a 
variety of materials, including metals, ceramics, 
semiconductors, organics, polymers, and composites. The 
substrate includes the base to which the microneedles are 
attached or integrally formed. A reservoir may also be 
attached to the substrate. 
In one embodiment of the device, the substrate is formed 
from a thin, rigid material that is sufficiently stiff so as to 
force the attached microneedles through the biological bar-
rier in such areas where the barrier resists deformation by the 
microneedles. 
eedle. The annular bores may extend throughout all or a 
portion of the needle in the direction of the tip to the base, 
extending parallel to the direction of the needle or branching 
10 or exiting at a side of the needle, as appropriate. A solid or 
porous microneedle can be hollow. One of skill in the art can 
select the appropriate porosity and/or bore features required 
for specific applications. For example, one can adjust the 
pore size or bore diameter to permit passage of the particular 
15 material to be transported through the microneedle device. 
The inner surface of the bore of hollow micro needles can be 
made rough to enhance cell membrane disruption for those 
applications in which cell disruption is useful. 
In a preferred embodiment of the device, the substrate is 
formed from flexible materials to allow the device to fit the 20 
The microneedles can have straight or tapered shafts. A 
hollow microneedle that has a substantially uniform 
diameter, which needle does not taper to a point, is referred 
to herein as a "microtube." As used herein, the term 
"microneedle" includes both microtubes and tapered needles 
unless otherwise indicated. In one embodiment, the diameter 
contours of the biological barrier, and to adapt to barrier 
deformations that may occur when the microneedle device is 
applied. A flexible device further facilitates more consistent 
penetration during use, since penetration can be limited by 
deviations in the attachment surface. For example, the 
surface of human skin is not fiat due to dermatoglyphics, i.e. 
tiny wrinkles, and hair, and is highly deformable. The 
flexible substrate can be deformed mechanically (for 
example, using an actuator or simply by fluid pressure) in 
order to pierce the biological barrier. 
b. Microneedle 
The microneedles of the device can be constructed from 
a variety of materials, including metals, ceramics, 
semiconductors, organics, polymers, and composites. Pre-
ferred materials of construction include pharmaceutical 
grade stainless steel, gold, titanium, nickel, iron, gold, tin, 
chromium, copper, alloys of these or other metals, silicon, 
silicon dioxide, and polymers. Representative biodegradable 
polymers include polymers of hydroxy acids such as lactic 
acid and glycolic acid polylactide, polyglycolide, 
polylactide-co-glycolide, and copolymers with PEG, 
polyanhydrides, poly( ortho )esters, polyurethanes, poly 
(butyric acid), poly(valeric acid), and poly(lactide-co-
caprolactone ). Representative non-biodegradable polymers 
include polycarbonate, polymethacrylic acid, ethylenevinyl 
acetate, polytetrafiuoroethylene (TEFLON™), and polyes-
ters. 
Generally, the microneedles should have the mechanical 
strength to remain intact for delivery of drugs, or serve as a 
conduit for the collection of biological fluid, while being 
inserted into the skin, while remaining in place for up to a 
number of days, and while being removed. In embodiments 
where the microneedles are formed of biodegradable 
polymers, however, this mechanical requirement is less 
stringent, since the microneedles or tips thereof can break 
off, for example in the skin, and will biodegrade. 
Nonetheless, even a biodegradable microneedle still needs 
to remain intact at least long enough for the microneedle to 
serve its intended purpose (e.g., its conduit function). 
Therefore, biodegradable microneedles can provide an 
increased level of safety, as compared to nonbiodegradable 
ones. 
The microneedles can be formed of a nonporous solid, a 
porous solid (with or without a sealed coating or exterior 
portion), or hollow. As used herein, the term "porous" means 
having pores or voids throughout at least a portion of the 
microneedle structure, sufficiently large and sufficiently 
25 of the microneedle is greatest at the base end of the micron-
eedle and tapers to a point at the end distal the base. The 
microneedle can also be fabricated to have a shaft that 
includes both a straight (untapered) portion and a tapered 
30 
portion. 
The microneedles can be formed with shafts that have a 
circular cross-section in the perpendicular, or the cross-
section can be non-circular. For example, the cross-section 
of the microneedle can be polygonal (e.g. star-shaped, 
square, triangular), oblong, or another shape. The shaft can 
35 have one or more bores. The cross-sectional dimensions 
typically are between about 10 nm and 1 mm, preferably 
between 1 micron and 200 microns, and more preferably 
between 10 and 100 µm. The outer diameter is typically 
between about 10 µm and about 100 µm, and the inner 
40 diameter is typically between about 3 µm and about 80 µm. 
The length of the microneedles typically is between about 
1 µm and 1 mm, preferably between 10 microns and 500 
microns. The length is selected for the particular application, 
accounting for both an inserted and uninserted portion. An 
45 array of microneedles can include a mixture of micro needles 
having, for example, various lengths, outer diameters, inner 
diameters, cross-sectional shapes, and spacing between the 
microneedles. 
The microneedles can be oriented perpendicular or at an 
50 angle to the substrate. Preferably, the microneedles are 
oriented perpendicular to the substrate so that a larger 
density of microneedles per unit area of substrate is pro-
vided. An array of microneedles can include a mixture of 
microneedle orientations, heights, or other parameters. 
55 c. Reservoir 
The microneedle device may include a reservoir in com-
munication with the microneedles. The reservoir can be 
attached to the substrate by any suitable means. In a pre-
ferred embodiment, the reservoir is attached to the back of 
60 the substrate (opposite the micro needles) around the 
periphery, using an adhesive agent (e.g., glue). A gasket may 
also be used to facilitate formation of a fluid-tight seal. 
In a preferred embodiment, the reservoir contains drug, 
for delivery through the microneedles. The reservoir may be 
65 a hollow vessel, a porous matrix, or a solid form including 
drug which is transported therefrom. The reservoir can be 
formed from a variety of materials that are compatible with 
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the drug or biological fluid contained therein. Preferred 
materials include natural and synthetic polymers, metals, 
ceramics, semiconductors, organics, and composites. In one 
embodiment, the reservoir is a standard syringe. 
8 
Flow of molecules through the microneedles can occur 
based on diffusion, capillary action, or can be induced using 
conventional mechanical pumps or nonmechanical driving 
forces, such as electroosmosis or electrophoresis, or con-
The microneedle device can include one or a plurality of 
chambers for storing materials to be delivered. In the 
embodiment having multiple chambers, each can be in fluid 
connection with all or a portion of the microneedles of the 
device array. In one embodiment, at least two chambers are 
used to separately contain drug (e.g., a lyophilized drug, 
such as a vaccine) and an administration vehicle (e.g., 
saline) in order to prevent or minimize degradation during 
storage. Immediately before use, the contents of the cham-
bers are mixed. Mixing can be triggered by any means, 
including, for example, mechanical disruption (i.e. punctur-
ing or breaking), changing the porosity, or electrochemical 
degradation of the walls or membranes separating the cham-
bers. In another embodiment, a single device is used to 
deliver different drugs, which are stored separately in dif-
ferent chambers. In this embodiment, the rate of delivery of 
each drug can be independently controlled. 
s vection. For example, in electroosmosis, electrodes are 
positioned on the biological barrier surface, one or more 
microneedles, and/or the substrate adjacent the needles, to 
create a convective flow which carries oppositely charged 
ionic species and/or neutral molecules toward or into the 
10 biological barrier. In a preferred embodiment, the micron-
eedle device is used in combination with another mechanism 
that enhances the permeability of the biological barrier, for 
example by increasing cell uptake or membrane disruption, 
using electric fields, ultrasound, chemical enhancers, 
15 vacuum viruses, pH, heat and/or light. 
Passage of the micro needles, or drug to be transported via 
the microneedles, can be manipulated by shaping the 
microneedle surface, or by selection of the material forming 
the microneedle surface (which could be a coating rather 
In a preferred embodiment, the reservoir should be in 
direct contact with the microneedles and have holes through 
which drug could exit the reservoir and flow into the interior 
of hollow or porous microneedles. In another preferred 
embodiment, the reservoir has holes which permit the drug 
to transport out of the reservoir and onto the skin surface. 
From there, drug is transported into the skin, either through 
hollow or porous microneedles, along the sides of solid 
microneedles, or through pathways created by microneedles 
in the skin. 
20 than the microneedle per se). For example, one or more 
grooves on the outside surface of the microneedles can be 
used to direct the passage of drug, particularly in a liquid 
state. Alternatively, the physical surface properties of the 
microneedle can be manipulated to either promote or inhibit 
25 transport of material along the microneedle surface, such as 
by controlling hydrophilicity or hydrophobicity. 
The flow of molecules can be regulated using a wide 
range of valves or gates. These valves can be the type that 
are selectively and repeatedly opened and closed, or they can 
d. Transport Control Components 
30 be single-use types. For example, in a disposable, single-use 
drug delivery device, a fracturable barrier or one-way gate 
may be installed in the device between the reservoir and the 
opening of the microneedles. When ready to use, the barrier 
can be broken or gate opened to permit flow through the 
The microneedle device also must be capable of trans-
porting material across the barrier at a useful rate. For 
example, the microneedle device must be capable of deliv-
ering drug across the skin at a rate sufficient to be thera-
peutically useful. The device may include a housing with 
microelectronics and other micromachined structures to 
control the rate of delivery either according to a prepro-
grammed schedule or through active interface with the 
patient, a healthcare professional, or a biosensor. The rate 
can be controlled by manipulating a variety of factors, 
including the characteristics of the drug formulation to be 
delivered (e.g., its viscosity, electric charge, and chemical 
composition); the dimensions of each microneedle (e.g., its 
outer diameter and the area of porous or hollow openings); 45 
the number of micro needles in the device; the application of 
35 microneedles. Other valves or gates used in the microneedle 
devices can be activated thermally, electrochemically, 
mechanically, or magnetically to selectively initiate, 
modulate, or stop the flow of molecules through the needles. 
In a preferred embodiment, flow is controlled by using a 
40 rate-limiting membrane as a "valve." 
a driving force (e.g., a concentration gradient, a voltage 
gradient, a pressure gradient); and the use of a valve. 
The rate also can be controlled by interposing between the 
drug in the reservoir and the opening(s) at the base end of the so 
microneedle polymeric or other materials selected for their 
diffusion characteristics. For example, the material compo-
sition and layer thickness can be manipulated using methods 
known in the art to vary the rate of diffusion of the drug of 
interest through the material, thereby controlling the rate at ss 
which the drug flows from the reservoir through the micron-
eedle and into the tissue. 
Transportation of molecules through the micro needles can 
The microneedle devices can further include a flowmeter 
or other means to monitor flow through the microneedles 
and to coordinate use of the pumps and valves. 
e. Sensors 
Useful sensors may include sensors of pressure, 
temperature, chemicals, and/or electromagnetic fields. Bio-
sensors can be located on the microneedle surface, inside a 
hollow or porous microneedle, or inside a device in com-
munication with the body tissue via the microneedle (solid, 
hollow, or porous). These microneedle biosensors can 
include four classes of principal transducers: potentiometric, 
amperometric, optical, and physiochemical. An amperomet-
ric sensor monitors currents generated when electrons are 
exchanged between a biological system and an electrode. 
Blood glucose sensors frequently are of this type. 
The microneedle may function as a conduit for fluids, 
solutes, electric charge, light, or other materials. In one 
embodiment, hollow microneedles can be filled with a 
substance, such as a gel, that has a sensing functionality 
60 associated with it. In an application for sensing based on 
binding to a substrate or reaction mediated by an enzyme, 
the substrate or enzyme can be immobilized in the needle 
interior, which would be especially useful in a porous needle 
be controlled or monitored using, for example, various 
combinations of valves, pumps, sensors, actuators, and 
microprocessors. These components can be produced using 
standard manufacturing or microfabrication techniques. 
Actuators that may be useful with the microneedle devices 
disclosed herein include micropumps, microvalves, and 
positioners. In a preferred embodiment, a microprocessor is 65 
programmed to control a pump or valve, thereby controlling 
the rate of delivery. 
to create an integral needle/sensor. 
Wave guides can be incorporated into the microneedle 
device to direct light to a specific location, or for detection, 
for example, using means such as a pH dye for color 
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evaluation. Similarly, heat, electricity, light or other energy 
forms may be precisely transmitted to directly stimulate, 
damage, or heal a specific tissue or intermediary (e.g., tattoo 
removal for dark skinned persons), or diagnostic purposes, 
such as measurement of blood glucose based on IR spectra 5 
or by chromatographic means, measuring a color change in 
the presence of immobilized glucose oxidase in combination 
with an appropriate substrate. 
f. Attachment Features 
10 
than about 1 µm, to avoid making a hole which would allow 
bacteria to enter the penetration wound. The actual micron-
eedle diameter should be larger than 1 µm, since the hole 
likely will contract following withdrawal of the micron-
eedle. The diameter of microneedle 12 more preferably is 
between about 1 µm and 100 µm. Larger diameter and longer 
microneedles are acceptable, so long as the microneedle can 
penetrate the biological barrier to the desired depth and the 
hole remaining in the skin or other tissue following with-
A collar or flange also can be provided with the device, for 
example, around the periphery of the substrate or the base. 
It preferably is attached to the device, but alternatively can 
10 drawal of the microneedle is sufficiently small, preferably 
small enough to exclude bacterial entry. The microneedles 
12 can be solid or porous, and can include one or more bores 
connected to upper portion 11. be formed as an integral part of the substrate, for example by 
forming microneedles only near the center of an "oversized" 
substrate. The collar can also emanate from other parts of the 15 
device. The collar can provide an interface to attach the 
microneedle array to the rest of the device, and can facilitate 
handling of the smaller devices. 
h. Microneedle Penetration Enhancing Features 
In a preferred embodiment, the microneedle devices 
include features which improve penetration of the micron-
eedles into deformable, elastic biological barriers, such as 
human skin. As used herein, "improved penetration" refers 
to providing more uniform, better controlled insertion of In a preferred embodiment, the microneedle device 
includes an adhesive to temporarily secure the device to the 
surface of the biological barrier. The adhesive can be essen-
tially anywhere on the device to facilitate contact with the 
biological barrier. For example, the adhesive can be on the 
surface of the collar (same side as microneedles), on the 
surface of the substrate between the microneedles (near the 
base of the microneedles), or a combination thereof. 
20 microneedles, for example, as compared to manual insertion 
of a microneedle or array of microneedles into skin without 
compensation (in the device design or site preparation or 
both) for deformation of the skin at the intended site of 
insertion. This is particularly critical for devices which 
In one embodiment, the microneedle device is incorpo-
rated into an arm (e.g., wrist) band. The arm band can be 
conveniently worn by a patient for drug delivery, sampling 
of biological fluids, or both over a prolonged period of time, 
such as several hours. 
25 include a three dimensional array of the micro needles. These 
features typically function to (1) adapt to the deformation, 
(2) limit the deformation, and/or (3) utilize alternate ways of 
creating the holes in the biological barrier for the micron-
eedles to enter. These penetration enhancing techniques 
g. Transdermal Microneedle Device 
30 generally can be used with solid, porous, or hollow micron-
eedles. Examples of penetration enhancing features include 
the following: 
i. Microneedle Extensions 
In a preferred embodiment for adapting the device to the 
35 elasticity of skin, the microneedles of the device include 
extensions, also called protrusion enhancers. One solution to 
enhance microneedle penetration would be to make the 
microneedles much longer. However, very tall, small diam-
eter microneedles would tend to be structurally fragile. 
FIG. 9 is a side elevational view of a schematic of an 
embodiment of the microneedle device inserted into unde-
formed skin. The device 10 includes an upper portion or 
substrate 11 from which a plurality of microneedles 12 
protrude. The height of the upper portion 11 is between 
about 1 µm and 1 cm, and the width of the upper portion is 
between about 1 mm and 10 cm. The upper portion 11 of the 
device can be solid or hollow, and may include multiple 
compartments. In a preferred embodiment for drug delivery, 
the upper portion 11 contains one or more drugs to be 
delivered. It is also preferred that the upper portion include 
one or more sensors and/or an apparatus (e.g., pump or 
electrode) to drive (provide/direct the force) transport of the 45 
drug or other molecules. 
40 Therefore, a relatively wider, yet tall base is provided 
between the substrate and the microneedle to increase the 
The height (or length) of the microneedles 12 generally is 
between about 1 µm and 1 mm. The diameter and length 
both affect pain as well as functional properties of the 
needles. In one embodiment for transdermal applications, 50 
the "insertion depth" of the microneedles 12 is less than 
about 100 µm, more preferably about 30 µm, so that inser-
tion of the micro needles 12 into the skin through the stratum 
corneum 14 does not penetrate through the epidermis 16 into 
the dermis 18 (as described below), thereby avoiding con- 55 
tacting nerves and reducing the potential for causing pain. In 
such applications, the actual length of the microneedles may 
be longer, since the portion of the micro needles distal the tip 
may not be inserted into the skin; the uninserted length 
depends on the particular device design and configuration. 60 
The actual (overall) height or length of micro needles 12 
should be equal to the insertion depth plus the uninserted 
length. Other embodiments using sufficiently small micron-
eedles may penetrate into the dermis without causing pain. 
The diameter of each microneedle 12 generally is between 65 
about 10 nm and 1 mm, and preferably leaves a residual hole 
(following microneedle insertion and withdrawal) of less 
length while maintaining structural integrity of the micron-
eedles. The extensions can be fabricated using the same 
microfabrication techniques described herein or other con-
ventional fabrication techniques, and typically are made 
integrally with the substrate and microneedles. The exten-
sions can be of any cross-sectional shape, are typically 
between about 500 µm and 10 mm in height, and generally 
are at least about 200 µm in diameter for a single needle/ 
single extension configuration. A single extension can sup-
port one or more microneedles. 
The extensions also can be designed to function as a 
penetration stop or limiter, to limit the depth of microneedle 
penetration. 
FIGS. lOa-c illustrate several non-limiting embodiments 
of the extensions. Device 110 includes substrate 112, exten-
sion 114, and microneedle(s) 116. The figures show a single 
needle/single extension configuration (lOa ), a multiple 
needle/single extension configuration (lOb), and a multiple 
needle/multiple extension configuration (lOc). The micron-
eedle devices can include arrays of microneedles and exten-
sions in essentially any combination and number. 
FIG. lOd illustrates an embodiment of a microneedle 
device 180 having extension 182 terminating in microneedle 
array 184. The device also includes shoulder 186 and key 
(cutout) 188, which serve to control stretching of the skin at 
the site of microneedle insertion to enhance penetration. 
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Specifically, the skin stretches in the key 188 as the micron-
eedle device 180 is pushed in, while shoulder 186 simulta-
neously limits the area of skin being stretched. 
ii. Optimized Microneedle Spacing 
12 
device 250 include microneedles 252, which are fabricated 
on a flexible substrate 254. The substrate is laminated to a 
preformed membrane bubble 256, such as those which are 
used as a membrane switch. This laminated structure is 
5 attached to holder 258. In another embodiment to adapt to the deformability of 
skin, the microneedle device includes arrays of micron-
eedles having spaces between the microneedles or between 
arrays of microneedles, wherein the spacings permit areas of 
the skin to fill the spaces in order to enhance microneedle 
contact with adjacent areas of the skin. The spacing is 10 
designed to adapt to the skin's radius of curvature to 
overcome the penetration problem. 
The molecules to be delivered, e.g., drug, are contained in 
a chamber 260 formed between the membrane bubble 256 
and the substrate 254. The molecules are sealed inside the 
chamber either at the laminating step or are filled after 
lamination, for example, by injection through the mem-
brane. A sponge or similar device (not shown) may be 
incorporated into the chamber 260 to contain the molecules 
before insertion and delivery. The sponge device is com-
pressed by the bubble membrane as it turns to its downward 
position (see FIG. 18b). 
FIG. 19 illustrates a microneedle device 300 having 
arrays of microneedles 302 with spaces 304 between the 
arrays. Spaces 304 have a size between about one and ten 15 
times, preferably between about one and two times, the size In operation, the device 250 is pressed against the skin, 
wherein the holder 258 positions the microneedles 252 
against the skin, as shown in FIG. 18a. Then, force is applied 
to the membrane bubble 256, flipping it through its transition 
of the arrays 302. This spacing effect can be achieved using 
some configurations of the microneedle extensions 
described above. 
iii. Linear and Curved Arrays of Microneedles 
In another embodiment for adapting the device to the 
elasticity of skin, the microneedles are provided in a curved 
three dimensional array. For example, the microneedle 
device can have a rigid substrate which forms a curved, 
rather than planar, surface. The substrate can be, for 
example, hemispherical or elliptical. The device, by present-
ing the needles with a curved surface, can provide improved 
uniformity of penetration among the microneedles of an 
array, as illustrated in FIG. lla. This same effect also can be 
achieved by varying the height of the microneedles in the 
array having a planar substrate, as shown in FIG. llb. 
In a preferred embodiment, two dimensional (i.e. linear) 
arrays are used. A preferred embodiment of a linear array 
microneedle device is shown in FIG. llc. Device 220 
includes substrate 222, which is formed into a U-shape, and 
an array of microneedles 224 at the apex of substrate 222. 
The substrate/microneedle portion is mounted over the end 
of a slotted holder 226. Molecules for transport through the 
microneedles 224 flow through one or more slots 228 
positioned at the end of the slotted holder 226. The device 
also includes a fitting portion 230 which is integral with or 
attached to the slotted holder 226. The fitting portion 230 can 
be, for example, a female Luer lock for attachment to a 
conventional syringe. The use of a linear array such as in this 
device readily deforms the skin at a sharp radius over the tips 
of the micro needles 224, greatly facilitating their penetration 
into the skin. 
In a variation of this embodiment, several linear arrays of 
microneedles can be combined onto a single fitting portion 
or holder in order to increase the area of injection. By 
spacing the arrays on the holder widely enough, the correct 
skin deformation can be maintained. The spacing is selected 
to be sufficient to allow the skin or other barrier to reach a 
20 state to the down position. This action applies pressure to the 
molecules in the chamber 260, expanding the substrate 254 
of the microneedle array and pushing the microneedles 252 
through the skin. Subsequently, the pressure forces the 
molecules through the microneedles 252 and into the skin. 
25 It The change in pressure upon the membrane bubble must 
occur faster and be larger than can be relieved by the flow 
of molecules through the microneedles, in order to achieve 
effective delivery. 
In an alternative embodiment, the chamber 260 may 
30 include an intermediate septum or equivalent divider (not 
shown) which can be ruptured or moved to permit the 
molecules to flow through the microneedles 252. For 
example, the user applies pressure to the membrane bubble, 
which pressure first forces the microneedles into the skin, as 
35 shown in FIG. 18b, and then ruptures the septum to deliver 
drugs through the needle and into the skin. 
v. High Velocity Insertion 
In another embodiment, the microneedles are applied to 
the skin surface at an increased velocity, thereby reducing 
40 the time available for the stratum corneum and underlying 
tissues to deform from contact with the tips of the micron-
eedles. The insertion can be by forcing the microneedles into 
the skin, forcing the skin into the microneedles, or a com-
bination thereof. This more rapid microneedle/skin contact 
45 can occur, for example, by releasing a compressed spring or 
other elastic device that pushes or pulls the microneedles, or 
by a rapid burst release of compressed gas against the back 
of the substrate. Alternatively, the skin could be forced by 
rapidly pulling a vacuum or pushing the skin from the sides 
50 (pinching) at the site of micro needle administration to cause 
the skin to be pulled up against an array of microneedles. 
Various combinations of these mechanisms can be used 
together. The mechanisms typically are integrated into the 
microneedle device. relaxed state in the region between the arrays, thus facili-
tating the correct deformation over each needle array in a 55 
manner independent of other arrays. 
vi. Limiting Biological Barrier Elasticity 
In preferred embodiments for limiting the elasticity I 
deformation of tissue, the microneedle device includes fea-
tures suitable for stretching, pulling, or pinching the tissue, 
particularly skin, to present a more rigid surface in the area 
These microneedle devices are fabricated using or adapt-
ing the same microfabrication techniques described herein. 
In one embodiment, microneedle arrays can be fabricated on 
flexible substrates, which then are mounted onto rigid 
spherical, cylindrical, or elliptical surfaces. 
iv. Flexible Substrates 
The substrate also can be flexible so that it deforms with 
the skin or other barrier upon application of the micro needle 
array. 
FIGS. 18a-b illustrate a preferred embodiment of a 
microneedle device having a flexible substrate. In this case, 
60 to which the micro needles are applied (i.e. penetrate) as 
illustrated in FIGS. 12a-c. 
It may also be useful to cool the stratum corneum to 
reduce its elasticity and/or to apply chemicals to the skin 
surface to "tighten" the skin and reduce its elasticity. For 
65 example, the skin surface may be cooled by directing a flow 
of cold gas through the microneedles onto the skin surface. 
The flow of cold gas can be generated, for example, from a 
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liquefied gas source such as nitrogen, carbon dioxide, or a 
refrigerant such as FREON™. The skin also can be cooled 
by contact with a cooling (e.g., refrigerated) element, such 
14 
device 200 includes body portion 202 having an inner 
vacuum ring 204 and an outer vacuum ring 206, separated 
by a ring-shaped microneedle array (not shown). The use of 
coaxial suction rings provides a uniform deformation force as a plate, or the microneedles themselves can function as 
the cooling element. The cooling element should provide 
sufficient local cooling of the stratum corneum so as to 
stiffen the stratum corneum in the vicinity of each needle 
sufficiently to enhance penetration. These cooling means can 
be used independently or in combination with chemical 
means to tighten the skin. Examples of chemical means 
include biocompatible organic solvents, such as isopropanol 
or acetone, which tend to dry out and stiffen the skin surface, 
5 on the skin. The amount of deformation can be controlled by 
varying the absolute and relative sizes of the annular 
vacuum rings, and by controlling the amount of vacuum 
pulled, for example, by a suction pump. The relative height 
of the inner and outer rings, and their height relative to the 
or such astringent chemicals that can be topically applied to 
the skin before microneedle insertion. 
10 microneedle array, can be varied to change the skin defor-
mation and consequent pressure onto the microneedle array. 
In the device shown, molecules, typically as a fluid, are 
delivered through a port 208 in the annular ring holding the 
microneedles, and to the whole ring-shaped array through a 
a. Suction 15 circular fluidics channel 210 adjacent the substrate of the 
microneedles. The device shown includes a female Luer Suction can be used to hold the skin in place during the 
insertion of the microneedle, limiting the deflection and 
deformation of skin in contact with the tips of the micron-
eedles. Suction also can be used to bring skin in contact with 
stationary microneedles, and if sufficiently great, can cause 20 
the skin to be pierced by the microneedles. The suction may 
also enhance systemic delivery of drug by increasing blood 
flow in the area of administration via the microneedles, or 
may enhance withdrawal of interstitial fluid or blood for 
analysis/sensing. The suction typically is induced by creat- 25 
ing a vacuum on the skin at the site of microneedle appli-
cation. The vacuum induced is between about 10 and 2000 
mm Hg, preferably between about 50 and 300 mm Hg, at the 
site of application. The suction typically can occur before, 
simultaneously with, or following insertion of the micron- 30 
eedles. 
lock 212 for attachment to a conventional syringe, as well as 
tubing section 214 that can be used to connect the device to 
a vacuum pump of some kind, either manually or power 
driven. 
b. Stretching 
Stretching can also be used to limit the deflection and 
deformation of skin in contact with the tips of the micron-
eedles. The stretching can be effected by a separate device 
or incorporated as a feature of the microneedle device itself. 
FIGS. 14a-b shows one embodiment of a microneedle 
device that includes a stretching component. Microneedle 
device 150 includes flexible stretching cone 152, which 
includes circular outer rim 156 and surrounds microneedles 
154. FIG. 14a shows device 150 with the stretching cone 
152 in its normal, relaxed form and shape (i.e. no net forces 
applied to it) resting on the skin surface, with the tips of 
microneedles 154 terminating inside stretching cone 152. 
FIG. 14b shows device 150 following application of pres-
35 sure (e.g., manual pressure) on device 150 toward the skin. 
Examples of microneedle devices adapted to create a 
vacuum are shown in FIGS. 13a-c. FIG. 13a shows device 
120 which includes substrate 122, microneedle array 124, 
and reservoir 126, which is partially enclosed by outer 
chamber 128. Outer chamber 128 includes a port 127 
through which air or other fluids within the chamber are 
withdrawn following, and/or before, contact of the opening 
rim 129 to the skin surface. The outer chamber 128 can be 
made of flexible or rigid material, and generally is gas 
impermeable. A source of vacuum, e.g., a vacuum pump, 
typically is adapted to be in fluid communication with port 
127. A micro-battery-powered vacuum pump can be inte-
grated into the device to provide this function. In another 
embodiment, outer chamber 128 can be evacuated, so that 45 
when triggered, the skin at the site of administration is 
exposed to the vacuum and is pulled up into the device. This 
embodiment effects a short pulse of vacuum, without requir-
ing extra equipment. In another embodiment, a tool can be 
used to mechanically create the necessary vacuum upon 50 
manual activation. 
FIG. 13b is a variation of the device shown in FIG. 13a, 
wherein device 130 includes two coaxial cylinders, outer 
cylinder 132 and inner cylinder 134. Vacuum is induced in 
the space between the cylinders. Inner cylinder 134 termi-
nates with reservoir 136, substrate 138, and microneedles 
140. Outer cylinder 132 and its rim 139 function as the outer 
chamber 128 and opening rim 129 in FIG. 13a. Optionally, 
an overpressure can be applied in the inner cylinder 134 to 
facilitate flow, e.g. of drug, from reservoir 136 through the 
microneedles 140. The device can be designed to have the 
inner cylinder 134 and microneedles 140 in a position fixed 
or movable with respect to the outer cylinder 132, as 
appropriate. In other embodiments, the device can have a 
non-cylindrical shape. 
A preferred embodiment of a suction device for use with 
a microneedle array is shown in FIG. 13c. The suction 
As the force is applied, outer rim 156 begins to "flatten" and 
frictionally engages the skin surface, stretching the skin 
away from and perpendicular to the central axis of the 
stretching cone 152, while the microneedles 154 move into 
40 contact with and then penetrate the skin. The outer rim 156 
should be roughened, knurled, have teeth, or be formed of or 
coated with a sticky or non-slippery material so as to provide 
the necessary engagement between the surfaces. Examples 
of suitable materials include rubbers and synthetic polymers. 
In another embodiment, the device includes an aperture or 
other means of allowing gas trapped between the barrier and 
the device to escape. Examples of such apertures include one 
or more vent holes or slits, for example, through the side of 
the stretching cone 152. 
A preferred embodiment is shown in FIG. 14c, wherein 
stretching cone 152 is replaced with a plurality of, e.g., four, 
hinged stretching elements 153. The stretching elements 
stretch the skin laterally as device 150 is pressed down 
against the skin. The skin deflection is determined by the 
55 length of the stretcher element 153 relative to the length of 
the central cylinder 155. Like outer rim 156, the ends of the 
stretching elements 153 (distal the hinge end) preferably are 
roughened or knurled, have teeth, or are formed of or coated 
with a sticky or non-slippery material so as to control the 
60 friction between the skin and the stretching elements 153, 
thereby providing an additional means of controlling the 
stretching force. The device shown in FIG. 14c is connected 
to a standard female Luer lock 157, for attachment to a 
standard syringe. In a preferred embodiment, microneedles 
65 154 are aligned in columns and rows substantially parallel to 
the stretching element 153, so as to optimize the stretching 
force fore effective microneedle penetration. 
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In another embodiment, stretching of the skin is accom-
plished using a separate ring device, which can be pressed 
against the skin and then concentrically expanded to stretch 
the skin within the ring. For example, the ring device can be 
a rubber-coated metal band (having diameter x), which is 
compressed into a coil (having a diameter less than x). The 
coiled ring is then pressed against the skin and allowed to 
uncoil (i.e. expand to diameter x again), while frictionally 
engaging the skin, thereby stretching it. In a further 
embodiment, the ring device is configured as an iris that 
expands to stretch the skin upon mechanical actuation by 
engaging an actuation lever or rotary motion. 
c. Pinching 
16 
vii. Creating Holes for the Microneedles 
Another method of improving the penetration of biologi-
cal barriers with microneedles involves producing holes or 
pathways in the barrier through which the microneedles can 
5 traverse, other than the pathway created solely by forcing the 
microneedle into barrier. A variety of techniques can be 
adapted for use with the microneedle devices described 
herein. For example, U.S. Pat. No. 5,885,211 to Eppstein, et 
al. discloses several methods of selectively removing the 
10 
stratum corneum to enhance permeability of human skin. 
Some of these so-called microporation techniques disclosed 
can be adapted to promote penetration of microneedles into 
the viable epidermis. In a preferred embodiment, holes are 
created by vaporizing the stratum corneum, for example, by 
using a laser or by heating of the tips of the microneedles. 
Laser techniques are described, for example, in U.S. Pat. 
No. 5,885,211 to Eppstein, et al. and U.S. Pat. No. 4,775,361 
to Jacques et al. The laser, or pulsed light source, preferably 
is used in conjunction with a dye which substantially 
absorbs over the emission range of the light. The dye is 
Pinching can also be used to limit the deflection and 
deformation of skin in contact with the tips of the micron- 15 
eedles. In a preferred embodiment, the microneedle device 
includes jaws, typically one or more pair, which can be 
pressed against the skin surface and triggered to close 
against a segment of skin, as illustrated in FIGS. 15a-b. The 
size of the jaw opening can be selected based on the area of 
skin to be pinched to facilitate penetration of the micron-
eedle array selected for use. 
20 applied to the skin and the laser or light is focused on the 
dye, heating it. Then, the stratum corneum adjacent to the 
dye is heated by conduction, elevating the temperature of 
tissue-bound water and other vaporizable substances in the 
selected area above the vaporization point of the water and 
In FIGS. 15a-b, microneedle device 160 includes a pair 
of jaws 164 having flex or hinge points 168 and tips 166, 
positioned around microneedles 162. FIG. 15a shows the 
jaws 164 in the open position, and FIG. 15b shows the jaws 
164 in the closed position, pinching an area of skin which is 
drawn against the microneedle 162, causing the micron-
eedles to penetrate the skin. 
An alternative embodiment of the clamping device and 
method is illustrated in FIG. 15c. In this embodiment, a 
clamping device 170 is used to pinch the skin and provide 
a rigid support 172 behind a pinched section of skin, in order 
25 other vaporizable substances. This vaporization results in 
degradation of the stratum corneum at one or more select, 
i.e. pinpoint, areas, through which the microneedles can 
readily penetrate. One of skill in the art can readily select the 
appropriate dye, laser (e.g., Helium-Neon) or light source, 
30 and parameters of use, based, in part, on the particular 
microneedle array, drug to be delivered, and/or analyte to 
sample. In one embodiment, the light is focused, in part, by 
passing the light through the internal bore of a hollow 
microneedle. to present a surface of limited deformability for insertion of 
the microneedles 174. The clamping device 170 can be a 35 
separate device from the microneedle device 176, or the 
devices can be integrated into a single unit. 
Thermal ablation of the stratum corneum can be achieved 
by radiant heating (using a light/laser as described above) or 
by using conductive heating. For example, U.S. Pat. No. 
5,885,211 to Eppstein, et al. describes contacting human 
skin with a heat source (conductive heating) ablate the d. Adhesive Film Assist 
The deformation of skin can be reduced by applying a 
thin, adhesive film over the skin surface at the site of 
application. The film keeps the skin taut and limits defor-
mation at the site of microneedle insertion as the micron-
eedles are pushed through the film and into the skin. This is 
analogous to the use of a surgical tape that is applied to the 
skin before making a surgical incision. 
The adhesive film can include an expandable or shrink-
able material that is triggered to change size or shape prior 
to microneedle application, so as to stretch the skin thereby 
further limiting its deformability. For example, the material 
can be water-swellable, and wetted (triggering event) prior 
to microneedle application. In another example, the material 
can change form in response to a change in temperature 
(triggering event). 
40 stratum corneum. The microneedle devices described herein 
can be applied to the ablated skin and/or can be configured 
to provide the ablation of the stratum corneum, in particu-
larly by heating the microneedles to serve as the heat source 
which contacts the skin. Heating of the microneedles can be 
45 accomplished, for example, by (1) contacting the needles 
with an ohmic heating element, (2) providing microneedles 
formed of or coated with a conductive material, through 
which a modulated electrical current is passed to induce 
resistive heating of the microneedles, or (3) providing 
50 microneedles positioned in a modulatable alternating mag-
netic field of an excitation coil such that energizing the 
excitation coil with alternating current produces eddy cur-
rents sufficient to heat the microneedles by internal ohmic 
losses. The microneedles should be able to rapidly heat the 
55 skin surface at select spots to above 100° C., preferably 
above 123° C., to induce flash vaporization of the water 
content of the stratum corneum, as described in U.S. Pat. No. 
4,775,361 to Jacques et al. The heating preferably is done 
using an on/off cycling technique and/or adjacent cooling to 
The adhesive film must be thin enough for the micron-
eedles to penetrate both the film and the stratum corneum. If 
hollow microneedles are used, then the film should fracture 
upon penetration without substantial clogging of the hollow 
bore of the microneedles. Alternatively, the film could be 
formed of a woven or porous material so that the micron-
eedles substantially penetrate gaps or pores in the adhesive 
film rather than the fibers or matrix of the film material. 
Examples of suitable films include ethylene-
tetrafluoroethylene (ETFE) copolymer mesh (available from 
Goodfellow PLC) and porous films such as GORETEX™ 65 
(available from William H. Gore, Inc.) coupled with an 
appropriate acrylic adhesive. 
60 minimize damage to tissues adjacent the target area. In 
embodiments in which the microneedles are heated, the 
substrate preferably includes an insulating material, as 
shown in FIG. 16, which illustrates two hollow micron-
eedles and substrate in cross-section. 
Other embodiments include applying a jet or focused blast 
of high pressure fluid to hydraulically puncture the stratum 
corneum and form a micropore into which the microneedle 
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is inserted. The micropore preferably is slightly larger than 
the diameter of the microneedle. The microneedle device 
can be designed to utilize hollow microneedles to direct the 
18 
beam, flash, and shadowing and step coverage), sputtering, 
chemical vapor deposition (CVD), epitaxy (vapor phase, 
liquid phase, and molecular beam), electroplating, screen 
printing, lamination, stereolithography, laser machining, and jet of high pressure fluid. Various devices and techniques for 
high velocity introduction of fluids and particles into skin for 
delivery of drugs or genes are described, for example, in 
U.S. Pat. No. 5,919,159 and U.S. Pat. No. 5,599,302 to 
Lilley, et al. (Medi-Ject, Inc.), U.S. Pat. No. 5,899,880 to 
Bellhouse, et al. (PowderJect Research Ltd.), and U.S. Pat. 
No. 5,865,796 to McCabe (PowderJect Vaccines, Inc.). 
5 laser ablation (including projection ablation). See generally 
Jaeger, Introduction to Microelectronic Fabrication 
(Addison-Wesley Publishing Co., Reading Mass. 1988); 
Runyan, et al., Semiconductor Integrated Circuit Processing 
Technology (Addison-Wesley Publishing Co., Reading 
10 Mass. 1990); Proceedings of the IEEE Micro Electro 
Mechanical Systems Conference 1987-1998; Rai-
Choudhury, ed., Handbook of Microlithography, Microma-
chining& Micro/ abrication (SPIE Optical Engineering 
Creation of the holes and penetration can be enhanced by 
select cooling/freezing of the surface of the skin, e.g., 
cryoablation (see U.S. Pat. No. 5,147,355 to Friedman, et 
al.). For example, the microneedle device can be adapted to 
create a local Joule-Thompson effect (see U.S. Pat. No. 15 
5,758,505 to Dobak III, et al.). 
In another embodiment, chemical agents, such as certain 
keratin reducing agents (see U.S. Pat. No. 5,911,223 to 
Weaver et al.), can be applied at the site of administration to 
degrade the keratin of the skin's stratum corneum, rendering 20 
it more porous. Examples of suitable chemicals include 
sodium thiosulfate and urea. 
viii. Lubricated Microneedles 
Press, Bellingham, Wash. 1997). 
The following methods are preferred for making micron-
eedles. 
i. Electrochemical Etching of Silicon 
In this method, electrochemical etching of solid silicon to 
porous silicon is used to create extremely fine (on the order 
of 0.01 µm) silicon networks which can be used as piercing 
structures. This method uses electrolytic anodization of 
silicon in aqueous hydrofluoric acid, potentially in combi-
nation with light, to etch channels into the silicon. By 
varying the doping concentration of the silicon wafer to be In one embodiment, the microneedles include a lubricat-
ing material, such as TEFLON™ (polytetrafluoroethylene), 
coated onto the microneedles. In a preferred embodiment, 
the lubricating material is incorporated into metal 
microneedles, for example, by plating the lubricating mate-
rial with the metal during the manufacture of the micron-
eedles. 
25 etched, the electrolytic potential during etching, the incident 
light intensity, and the electrolyte concentration, control 
over the ultimate pore structure can be achieved. The 
material not etched (i.e. the silicon remaining) forms the 
microneedles. This method has been used to produce irregu-
ix. Vibrating the Microneedles 
30 lar needle-type structures measuring tens of nanometers in 
width. 
Essentially all of the microneedle devices and methods 
described herein can be adapted to vibrate the microneedles 
and/or the skin to further facilitate penetration. The vibration 
can be effected to move the microneedles perpendicular 35 
and/or parallel to the surface of the biological barrier, and/or 
at an orientation thereinbetween. The vibration motion can 
ii. Plasma Etching 
This process uses deep plasma etching of silicon to create 
microneedles with diameters on the order of 0.1 µm or 
larger. Needles are patterned directly using 
photolithography, rather than indirectly by controlling the 
voltage (as in electrochemical etching), thus providing 
greater control over the final microneedle geometry. 
In this process, an appropriate masking material (e.g., 
be induced using known techniques, the most common of 
which is coupling the microneedle or array thereof to a 
piezoelectric transducer that can provide the vibratory 
motion. Such a transducer can be bonded directly to the 
array or can be bonded to a reservoir, thereby utilizing the 
acoustic transmission properties of the reservoir contents 
(e.g., an aqueous drug solution) to transmit vibration to the 
microneedles. Alternatively, electromechanical actuation 
can be used to vibrate the microneedles, such electrome-
chanical actuation means include miniature motors and 
speaker coils. 
40 metal) is deposited onto a silicon wafer substrate and 
patterned into dots having the diameter of the desired 
microneedles. The wafer is then subjected to a carefully 
controlled plasma based on fluorine/oxygen chemistries to 
etch very deep, high aspect ratio trenches into the silicon. 
3. Methods of Making Microneedle Devices 
45 See, e.g., Jansen, et al., "The Black Silicon Method IV: The 
Fabrication of Three-Dimensional Structures in Silicon with 
High Aspect Ratios for Scanning Probe Microscopy and 
Other Applications," IEEE Proceedings of Micro Electro 
Mechanical Systems Conference, pp. 88-93 (1995). Those 
50 regions protected by the metal mask remain and form the 
needles. This method is further described in Example 1 The microneedle devices are made by microfabrication 
processes, by creating small mechanical structures in silicon, 
metal, polymer, and other materials. These microfabrication 
processes are based on well-established methods used to 
make integrated circuits, electronic packages and other 55 
microelectronic devices, augmented by additional methods 
used in the field of micromachining. The microneedle 
devices can have dimensions as small as a few nanometers 
and can be mass-produced at low per-unit costs. 
below. 
iii. Electroplating 
In this process, a metal layer is first evaporated onto a 
planar substrate. A layer of photoresist is then deposited onto 
the metal to form a patterned mold which leaves an exposed-
metal region in the shape of needles. By electroplating onto 
the exposed regions of the metal seed layer, the mold 
bounded by photoresist can be filled with electroplated 
a. Microfabrication Processes 60 material. Finally, the substrate and photoresist mold are 
removed, leaving the finished microneedle array. The 
microneedles produced by this process generally have diam-
eters on the order of 1 µm or larger. See, e.g., Frazier, et al., 
Microfabrication processes that may be used in making 
the microneedles disclosed herein include lithography; etch-
ing techniques, such as wet chemical, dry, and photoresist 
removal; thermal oxidation of silicon; electroplating and 
electroless plating; diffusion processes, such as boron, 65 
phosphorus, arsenic, and antimony diffusion; ion implanta-
tion; film deposition, such as evaporation (filament, electron 
"Two dimensional metallic microelectrode arrays for extra-
cellular stimulation and recording of neurons", IEEE Pro-
ceedings of the Micro Electro Mechanical Systems 
Conference, pp. 195-200 (1993). 
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iv. Other Processes 
20 
One or more distinct and continuous pathways are created 
through the interior of microneedles. In a preferred 
embodiment, the microneedle has a single annular pathway 
along the center axis of the microneedle. This pathway can 
Another method for forming microneedles made of sili-
con or other materials is to use microfabrication techniques 
such as photolithography, plasma etching, or laser ablation 
to make a mold form (A), transferring that mold form to 
other materials using standard mold transfer techniques, 
such as embossing or injection molding (B), and reproduc-
ing the shape of the original mold form (A) using the 
newly-created mold (B) to yield the final microneedles (C). 
Alternatively, the creation of the mold form (A) could be 
skipped and the mold (B) could be microfabricated directly, 
which could then be used to create the final microneedles 
5 be achieved by initially chemically or physically etching the 
holes in the material and then etching away microneedles 
around the hole. Alternatively, the microneedles and their 
holes can be made simultaneously or holes can be etched 
into existing microneedles. As another option, a microneedle 
(C). 
Another method of forming solid silicon microneedles is 
by using epitaxial growth on silicon substrates, as is utilized 
by Containerless Research, Inc. (Evanston, Ill., USA) for its 
products. 
10 form or mold can be made, then coated, and then etched 
away, leaving only the outer coating to form a hollow 
microneedle. Coatings can be formed either by deposition of 
a film or by oxidation of the silicon microneedles to a 
specific thickness, followed by removal of the interior 
b. Hollow or Porous Microneedles 
15 silicon. Also, holes from the backside of the wafer to the 
underside of the hollow needles can be created using a 
front-to-backside infrared alignment followed by etching 
from the backside of the wafer. 
In a preferred embodiment, microneedles are made with 
pores or other pathways through which material may be 20 
transported. The following descriptions outline representa-
tive methods for fabricating either porous or hollow micron-
eedles. 
i. Porous Microneedles 
a. Silicon Microneedles 
One method for hollow needle fabrication is to replace the 
solid mask used in the formation of solid needles by a mask 
that includes a solid shape with one or more interior regions 
of the solid shape removed. One example is a "donut-
shaped" mask. Using this type of mask, interior regions of 
Rather than having a single, well-defined hole down the 
length of the needle, porous needles are filled with a network 
of channels or pores which allow conduction of fluid or 
energy through the needle shaft. It has been shown that by 
appropriate electrochemical oxidation of silicon, pore arrays 
with high aspect ratios and a range of different pore size 
regimes can be formed; these pore regimes are defined as (1) 
microporous regime with average pore dimensions less than 
25 the needle are etched simultaneously with their side walls. 
Due to lateral etching of the inner side walls of the needle, 
this may not produce sufficiently sharp walls. In that case, 
two plasma etches may be used, one to form the outer walls 
of the microneedle (i.e., the 'standard' etch), and one to form 
30 the inner hollow core (which is an extremely anisotropic 
etch, such as in inductively-coupled-plasma "ICP" etch). For 
example, the ICP etch can be used to form the interior region 
of the needle followed by a second photolithography step 
and a standard etch to form the outer walls of the micron-
2 nm, (2) mesoporous regime with average pore sizes of 
between 2 nm and 50 nm, and (3) macroporous regime with 
pores greater than 50 nm. The mesoporous and macroporous 35 
regimes are expected to be most useful for drug delivery. 
Two approaches to porous needles are generally available, 
either (a) the silicon wafer is first made porous and then 
etched as described above to form needles or (b) solid 
microneedles are etched and then rendered porous, for 40 
example, by means of electrochemical oxidation, such as by 
anodization of a silicon substrate in a hydrofluoric acid 
electrolyte. The size distribution of the etched porous struc-
ture is highly dependent on several variables, including 
doping kind and illumination conditions, as detailed in 45 
Lehmann, "Porous Silicon-A New Material for MEMS", 
IEEE Proceedings of the Micro Electro Mechanical Systems 
Conference, pp. 1-6 (1996). Porous polymer or metallic 
microneedles can be formed, for example, by micromolding 
a polymer containing a volatilizable or leachable material, 50 
such as a volatile salt, dispersed in the polymer or metal, and 
then volatilizing or leaching the dispersed material, leaving 
a porous polymer matrix in the shape of the microneedle. 
ii. Hollow Needles 
eedle. FIG. la represents a silicon wafer 82 with a patterned 
photoresist layer 84 on top of the wafer 82. The wafer 82 is 
anisotropically etched (FIG. lb) to form a cavity 86 through 
its entire thickness (FIG. le). The wafer 82 is then coated 
with a chromium layer 88 followed by a second photoresist 
layer 90 patterned so as to cover the cavity 86 and form a 
circular mask for subsequent etching (FIG. ld). The wafer 
82 is then etched by a standard etch to form the outer tapered 
walls 92 of the microneedle (FIG. le). 
Alternatively, this structure can be achieved by substitut-
ing the chromium mask used for the solid microneedles 
described in Example 1 by a silicon nitride layer 94 on the 
silicon substrate 95 covered with chromium 96, deposited as 
shown in FIG. 2a and patterned as shown in FIG. 2a. Solid 
microneedles are then etched as described in Example 1 as 
shown FIG. 2c, the chromium 96 is stripped (FIG. 2d), and 
the silicon 95 is oxidized to form a thin layer of silicon 
dioxide 97 on all exposed silicon surfaces (FIG. 2e). The 
silicon nitride layer 94 prevents oxidation at the needle tip. 
The silicon nitride 94 is then stripped (FIG. 2f), leaving 
Three-dimensional arrays of hollow microneedles can be 
fabricated, for example, using combinations of dry etching 
processes (Laermer, et al., "Bosch Deep Silicon Etching: 
55 exposed silicon at the tip of the needle and oxide-covered 
silicon 97 everywhere else. The needle is then exposed to an 
ICP plasma which selectively etches the inner sidewalls of 
the silicon 95 in a highly anisotropic manner to form the Improving Uniformity and Etch Rate for Advanced MEMS 
Applications," Micro Electro Mechanical Systems, Orlando, 
Fla., USA, (Jan. 17-21, 1999); Despont et al., "High- 60 
Aspect-Ratio, Ultrathick, Negative-Tone Near-UV Photore-
sist for MEMS", Proc. of IEEE lO'h Annual International 
Workshop on MEMS, Nagoya, Japan, pp. 518-22 (Jan. 
26-30, 1997)); micromold creation in lithographically-
defined and/or laser ablated polymers and selective sidewall 65 
electroplating; or direct micromolding techniques using 
epoxy mold transfers. 
interior hole of the needle (FIG. 2g). 
Another method uses the solid silicon needles described 
previously as 'forms' around which the actual needle struc-
tures are deposited. After deposition, the forms are etched 
away, yielding the hollow structures. Silica needles or metal 
needles can be formed using different methods. Silica 
needles can be formed by creating needle structures similar 
to the ICP needles described above prior to the oxidation 
described above. The wafers are then oxidized to a con-
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process has been successfully performed on silicon and glass 
substrates (in which the upper surface is etched using 
isotropic wet or dry etching techniques) and copper-clad 
printed wiring board substrates. In the latter case, the copper 
trolled thickness, forming a layer on the shaft of the needle 
form which will eventually become the hollow microneedle. 
The silicon nitride is then stripped and the silicon core 
selectively etched away (e.g., in a wet alkaline solution) to 
form a hollow silica microneedle. 5 laminate is selectively removed using wet etching. Then a 
seed layer, such as Ti/Cu(fi (e.g., 30 nm/200 nm/30 nm), is 
conformally DC sputter-deposited onto the upper surface of 
the epoxy mold and onto the sidewalls of the cylindrical 
holes. The seed layer should be electrically isolated from the 
In a preferred embodiment, an array of hollow silicon 
microtubes is made using deep reactive ion etching com-
bined with a modified black silicon process in a conven-
tional reactive ion etcher, as described in Example 3 below. 
First, arrays of circular holes are patterned through photo-
resist into Si02 , such as on a silicon wafer. Then the silicon 
can be etched using deep reactive ion etching (DRIE) in an 
inductively coupled plasma (ICP) reactor to etch deep 
vertical holes. The photoresist was then removed. Next, a 
second photolithography step patterns the remaining Si02 
layer into circles concentric to the holes, leaving ring shaped 
oxide masks surrounding the holes. The photoresist is then 
removed and the silicon wafer again deep silicon etched, 
such that the holes are etched completely through the wafer 
(inside the Si02 ring) and simultaneously the silicon is 20 
etched around the Si02 ring leaving a cylinder. 
10 substrate. Subsequently, one or more electroplatable metals 
or alloys are electroplated onto the seed layer. Representa-
tive suitable metals and alloys include Ni, NiFe, Au, Cu, Cr, 
Pt, Pd, and Ti. The surrounding epoxy is then removed, 
leaving microtubes which each have an interior annular hole 
15 that extends through the base metal supporting the tubes. 
This latter process can be varied to produce hollow, 
tapered micro needles. After an array of holes is fabricated as 
described above, the photoresist and Si02 layers are 
replaced with conformal DC sputtered chromium rings. The 25 
second ICP etch is replaced with a SFd02 plasma etch in a 
reactive ion etcher (RIE), which results in positively sloping 
outer sidewalls. Henry, et al., "Micromachined Needles for 
the Transdermal Delivery of Drugs," Micro Electro 
Mechanical Systems, Heidelberg, Germany, pp. 494-98 30 
(Jan. 26-29, 1998). 
b. Metal Microneedles 
Metal needles can be formed by physical vapor deposition 
of appropriate metal layers on solid needle forms, which can 
The rate and duration of electroplating is controlled in order 
to define the wall thickness and inner diameter of the 
microtubes. In one embodiment, this method was used to 
produce microtubes having a height of between about 150 
and 250 µm, an outer diameter of between about 40 and 120 
µm, and an inner diameter of between about 30 and 110 µm 
(i.e., having a wall thickness of 10 µm). In a typical array, 
the microtubes have a tube center-to-center spacing of about 
150 µm, but can vary depending on the desired needle 
density. 
A variation of this method is preferred for forming tapered 
microneedles. As described above, photolithography yields 
holes in the epoxy which have vertical sidewalls, such that 
the resulting shafts of the microneedles are straight, not 
tapered. This vertical sidewall limitation can be overcome 
by molding a preexisting 3D structure, i.e., a mold-insert. 
The subsequent removal of the mold-insert leaves a mold 
which can be surface plated similarly to the holes produced 
by photolithography described above. 
Alternatively, non-vertical sidewalls can be produced 
directly in the polymeric mold into which electroplating will 
take place. For example, conventional photoresists known in 
the art can be exposed and developed in such as way as to 
have the surface immediately adjacent to the mask be wider 
be made of silicon using the techniques described above, or 35 
which can be formed using other standard mold techniques 
such as embossing or injection molding. The metals are 
selectively removed from the tips of the needles using 
electropolishing techniques, in which an applied anodic 
potential in an electrolytic solution will cause dissolution of 
metals more rapidly at sharp points, due to concentration of 
electric field lines at the sharp points. Once the underlying 
silicon needle forms have been exposed at the tips, the 
silicon is selectively etched away to form hollow metallic 
needle structures. This process could also be used to make 
hollow needles made from other materials by depositing a 
material other than metal on the needle forms and following 
the procedure described above. 
40 than the other surface. Specialized greyscale photoresists in 
combination with greyscale masks can accomplish the same 
effect. Laser-ablated molds can also be made with tapered 
sidewalls, e.g., by optical adjustment of the beam (in the 
case of serial hole fabrication) or of the reticle or mold 
A preferred method of fabricating hollow metal micron-
eedles utilizes micromold plating techniques, which are 
described as follows and in Examples 4 and 5. In a method 
for making metal microtubes, which does not require dry 
silicon etching, a photo-defined mold first is first produced, 
for example, by spin casting a thick layer, typically 150 µm, 
of an epoxy (e.g., SU-8) onto a substrate that has been coated 
with a thin sacrificial layer, typically about 10 to 50 nm. 
Arrays of cylindrical holes are then photolithographically 
defined through the epoxy layer, which typically is about 
150 µm thick. (Despont, et al., "High-Aspect-Ratio, 
Ultra thick, Negative-Tone Near-UV Photoresist for 
MEMS," Proc. of IEEE lO'h Annual International Workshop 
on MEMS, Nagoya, Japan, pp. 518-522 (Jan. 26-30, 1997)). 
The diameter of these cylindrical holes defines the outer 
diameter of the tubes. The upper surface of the substrate, the 
sacrificial layer, is then partially removed at the bottom of 
the cylindrical holes in the photoresist. The exact method 
chosen depends on the choice of substrate. For example, the 
45 during ablation (in the case of projection ablation). 
To form hollow tapered microneedles, the mold-insert is 
an array of solid silicon microneedles, formed as described 
in Henry, et al., "Micromachined Needles for the Transder-
mal Delivery of Drugs," Micro Electro Mechanical Systems, 
50 Heidelberg, Germany, pp. 494-498, Jan. 26-29 (1998). 
First, a layer of a material, such as an epoxy (e.g., SU-8 or 
a polydimethylsiloxane ("PDMS")), is spin cast onto the 
array of silicon microneedles to completely blanket the 
entire array. The epoxy settles during pre-bake to create a 
55 planar surface above the silicon needle tips; the material is 
then fully pre-baked, photolithographically cross-linked, 
and post-baked. 
The upper surface of the epoxy is then etched away, for 
example with an 0 2 /CHF3 plasma, until the needle tips are 
60 exposed, preferably leaving between about 1 and 5 µm of tip 
protruding from the epoxy. The silicon is then selectively 
removed, for example by using a SF6 plasma or a HNOiHF 
solution. The remaining epoxy micromold is the negative of 
the microneedles and has a small diameter hole where the tip 
65 of the microneedle formerly protruded. 
After the removal of the silicon, a seed layer, such as 
Ti-Cu-Ti, is conformally sputter-deposited onto the 
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epoxy micromold. Following the same process sequence 
described for hollow metal microtubes, one or more elec-
troplatable metals or alloys, such as Ni, NiFe, Au, or Cu, are 
electroplated onto the seed layer. Finally, the epoxy is 
removed, for example by using an 0 2 /CHF3 plasma, leaving 5 
an array of hollow metal microneedles. An advantage of 
using PDMS in this application is that the micromold can be 
physically removed from the silicon mold insert by 
mechanical means, such as peeling, without damaging the 
silicon mold insert, thus allowing the silicon mold insert to 
be reused. Furthermore, the electroplated microneedles can 
10 
be removed from the PDMS mold by mechanical means, for 
example by peeling, thereby allowing the PDMS to also be 
reused. In a preferred embodiment, this method is used to 
produce micro needles having a height of between about 150 
and 250 µm, an outer diameter of between about 40 and 120 15 
µm, and an inner diameter of between about 50 and 100 µm. 
In a typical array, the microtubes have a tube center-to-
center spacing of about 150 µm, but can vary depending on 
the desired needle density. The microneedles are 150 µm in 
height with a base diameter of 80 µm, a tip diameter of 10 20 
µm, and a needle-to-needle spacing of 150 µm. 
c. Silicon Dioxide Microneedles 
Hollow microneedles formed of silicon dioxide can be 
made by oxidizing the surface of the silicon microneedle 
forms (as described above), rather than depositing a metal 25 
and then etching away the solid needle forms to leave the 
hollow silicon dioxide structures. This method is illustrated 
in FIGS. 3a-d. FIG. 3a shows an array 24 of needle forms 
26 with masks 28 on their tips. In FIG. 3b, the needle forms 
26 have been coated with a layer 30 of metal, silicon dioxide 
or other material. FIG. 3c shows the coated needle forms 26 30 
with the masks 28 removed. Finally, in FIG. 3d, the needle 
forms 26 have been etched away, leaving hollow needles 30 
made of metal, silicon dioxide, or other materials. 
In one embodiment, hollow, porous, or solid microneedles 
are provided with longitudinal grooves or other modifica- 35 
tions to the exterior surface of the microneedles. Grooves, 
for example, should be useful in directing the flow of 
molecules along the outside of microneedles. 
d. Polymer Microneedles 
In a preferred method, polymeric microneedles are made 40 
using microfabricated molds. For example, the epoxy molds 
can be made as described above and injection molding 
techniques can be applied to form the microneedles in the 
molds (Weber, et al., "Micromolding-a powerful tool for 
the large scale production of precise microstructures", Proc. 45 
SPIE---International Soc. Optical Engineer. 2879:156-67 
(1996); Schift, et al., "Fabrication of replicated high preci-
sion insert elements for micro-optical bench arrangements" 
Proc. SPIE-International Soc. Optical Engineer. 
3513:122-34 (1998)). These micromolding techniques are 50 
preferred over other techniques described herein, since they 
can provide relatively less expensive replication, i.e. lower 
cost of mass production. In a preferred embodiment, the 
polymer is biodegradable. 
Microneedles, particularly hollow ones and ones formed 55 
of relatively brittle materials, may break at the juncture of 
the microneedle and substrate due to mechanical stresses at 
the sharp angle formed there. It has been found that the 
integrity of such microneedles can be improved by reinforc-
ing the base of the microneedles with an additional layer of 60 
material (e.g., silicon) applied onto the face of the substrate 
face adjacent the base end of the microneedles as shown in 
FIG. 17. 
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place for longer times (e.g., hours or days) for long-term 
transport of molecules. Depending on the dimensions of the 
device, the application site, and the route in which the device 
is introduced into (or onto) the biological barrier, the device 
may be used to introduce or remove molecules at specific 
locations. 
As discussed above, FIG. 9 shows a side elevational view 
of a schematic of a preferred embodiment of the micron-
eedle device 10 in a transdermal application. The device 10 
is applied to the skin such that the microneedles 12 penetrate 
through the stratum corneum and enter the viable epidermis 
so that the tip of the microneedle at least penetrates into the 
viable epidermis. In a preferred embodiment, drug mol-
ecules in a reservoir within the upper portion 11 flow 
through or around the microneedles and into the viable 
epidermis, where the drug molecules then diffuse into the 
dermis for local treatment or for transport through the body. 
To control the transport of material out of or into the 
device through the microneedles, a variety of forces or 
mechanisms can be employed. These include pressure 
gradients, concentration gradients, electricity, ultrasound, 
receptor binding, heat, chemicals, and chemical reactions. 
Mechanical or other gates in conjunction with the forces and 
mechanisms described above can be used to selectively 
control transport of the material. 
In particular embodiments, the device should be "user-
friendly." For example, in some transdermal applications, 
affixing the device to the skin should be relatively simple, 
and not require special skills. This embodiment of a micron-
eedle may include an array of microneedles attached to a 
housing containing drug in an internal reservoir, wherein the 
housing has a bioadhesive coating around the microneedles. 
The patient can remove a peel-away backing to expose an 
adhesive coating, and then press the device onto a clean part 
of the skin, leaving it to administer drug over the course of, 
for example, several days. 
a. Drug Delivery 
Essentially any drug or other bioactive agents can be 
delivered using these devices. Drugs can be proteins, 
enzymes, polysaccharides, polynucleotide molecules, and 
synthetic organic and inorganic compounds. Representative 
agents include anti-infectives, hormones, such as insulin, 
growth regulators, drugs regulating cardiac action or blood 
flow, and drugs for pain control. The drug can be for local 
treatment or for regional or systemic therapy. The following 
are representative examples, and disorders they are used to 
treat: 
Calcitonin, osteoporosis; Enoxaprin, anticoagulant; 
Etanercept, rheumatoid arthritis; Erythropoietin, anemia; 
Fentanyl, postoperative and chronic pain; Filgrastin, low 
white blood cells from chemotherapy; Heparin, anticoagu-
lant; Insulin, human, diabetes; Interferon Beta la, multiple 
sclerosis; Lidocaine, local anesthesia; Somatropin, growth 
hormone; and Sumatriptan, migraine headaches. 
In this way, many drugs can be delivered at a variety of 
therapeutic rates. The rate can be controlled by varying a 
number of design factors, including the outer diameter of the 
microneedle, the number and size of pores or channels in 
each microneedle, the number of microneedles in an array, 
the magnitude and frequency of application of the force 
driving the drug through the microneedle and/or the holes 
created by the microneedles. For example, devices designed 
to deliver drug at different rates might have more micron-
eedles for more rapid delivery and fewer microneedles for 
4. Microneedle Device Applications 
The device may be used for single or multiple uses for 
rapid transport across a biological barrier or may be left in 
65 less rapid delivery. As another example, a device designed to 
deliver drug at a variable rate could vary the driving force 
(e.g., pressure gradient controlled by a pump) for transport 
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according to a schedule which was pre-programmed or 
controlled by, for example, the user or his doctor. The 
devices can be affixed to the skin or other tissue to deliver 
drugs continuously or intermittently, for durations ranging 
from a few seconds to several hours or days. 
One of skill in the art can measure the rate of drug 
delivery for particular microneedle devices using in vitro 
and in vivo methods known in the art. For example, to 
measure the rate of transdermal drug delivery, human 
cadaver skin mounted on standard diffusion chambers can be 
used to predict actual rates. See Hadgraft & Guy, eds., 
Transdermal Drug Delivery: Developmental Issues and 
Research Initiatives (Marcel Dekker, New York 1989); 
Bronaugh & Maibach, Percutaneous Absorption, 
Mechanisms-Methodology-Drug Delivery (Marcel 
Dekker, New York 1989). After filling the compartment on 
the dermis side of the diffusion chamber with saline, a 
microneedle array is inserted into the stratum corneum; a 
drug solution is placed in the reservoir of the microneedle 
device; and samples of the saline solution are taken over 
time and assayed to determine the rates of drug transport. 
In an alternate embodiment, biodegradable or non-
biodegradable microneedles can be used as the entire drug 
delivery device, where biodegradable microneedles are a 
preferred embodiment. For example, the microneedles may 
be formed of a biodegradable polymer containing a disper-
sion of an active agent for local or systemic delivery. The 
agent could be released over time, according to a profile 
determined by the composition and geometry of the 
microneedles, the concentration of the drug and other fac-
tors. In this way, the drug reservoir is within the matrix of 
one or more of the microneedles. 
In another alternate embodiment, these microneedles may 
be purposefully sheared off from the substrate after pen-
etrating the biological barrier. In this way, a portion of the 
microneedles would remain within or on the other side of the 
biological barrier and a portion of the micro needles and their 
substrate would be removed from the biological barrier. In 
the case of skin, this could involve inserting an array into the 
skin, manually or otherwise breaking off the microneedles 
tips and then remove the base of the microneedles. The 
portion of the microneedles which remains in the skin or in 
or across another biological barrier could then release drug 
over time according to a profile determined by the compo-
sition and geometry of the microneedles, the concentration 
of the drug and other factors. In a preferred embodiment, the 
microneedles are made of a biodegradable polymer. The 
release of drug from the biodegradable microneedle tips can 
26 
b. Diagnostic Sensing of Body Fluids (Biosensors) 
One embodiment of the devices described herein may be 
used to remove material from the body across a biological 
barrier, i.e. for minimally invasive diagnostic sensing. For 
5 example, fluids can be transported from interstitial fluid in a 
tissue into a reservoir in the upper portion of the device. The 
fluid can then be assayed while in the reservoir or the fluid 
can be removed from the reservoir to be assayed, for 
diagnostic or other purposes. For example, interstitial fluids 
10 
can be removed from the epidermis across the stratum 
corneum to assay for glucose concentration, which should 
be useful in aiding diabetics in determining their required 
insulin dose. Other substances or properties that would be 
desirable to detect include lactate (important for athletes), 
oxygen, pH, alcohol, tobacco metabolites, and illegal drugs 
15 (important for both medical diagnosis and law enforcement). 
The sensing device can be in or attached to one or more 
microneedles, or in a housing adapted to the substrate. 
Sensing information or signals can be transferred optically 
(e.g., refractive index) or electrically (e.g., measuring 
20 changes in electrical impedance, resistance, current, voltage, 
or combination thereof). For example, it may be useful to 
measure a change as a function of change in resistance of 
tissue to an electrical current or voltage, or a change in 
response to channel binding or other criteria (such as an 
25 optical change) wherein different resistances are calibrated 
to signal that more or less flow of drug is needed, or that 
delivery has been completed. 
In one embodiment, one or more microneedle devices can 
be used for (1) withdrawal of interstitial fluid, (2) assay of 
30 the fluid, and/or (3) delivery of the appropriate amount of a 
therapeutic agent based on the results of the assay, either 
automatically or with human intervention. For example, a 
sensor delivery system may be combined to form, for 
example, a system which withdraws bodily fluid, measures 
35 its glucose content, and delivers an appropriate amount of 
insulin. The sensing or delivery step also can be performed 
using conventional techniques, which would be integrated 
into use of the microneedle device. For example, the micron-
eedle device could be used to withdraw and assay glucose, 
40 and a conventional syringe and needle used to administer the 
insulin, or vice versa. 
In an alternate embodiment, microneedles may be pur-
posefully sheared off from the substrate after penetrating the 
biological barrier, as described above. The portion of the 
45 microneedles which remain within or on the other side of the 
biological barrier could contain one or more biosensors. For 
example, the sensor could change color as its output. For 
microneedles sheared off in the skin, this color change could 
be controlled by the rate of polymer degradation. Micron- 50 
eedle tips can release drugs for local or systemic effect, or 
other agents, such as perfume, insect repellent and sun 
block. 
be observed through the skin by visual inspection or with the 
aid of an optical apparatus. 
The microneedles can also be used for aerosolization or 
delivery for example directly to a mucosal surface in the 
nasal or buccal regions or to the pulmonary system. 
Microneedle shape and content can be designed to control 
the breakage of microneedles. For example, a notch can be 55 
introduced into microneedles either at the time of fabrication 
The microneedle devices disclosed herein also should be 
useful for controlling transport across tissues other than 
skin. For example, microneedles can be inserted into the eye 
across, for example, conjunctiva, sclera, and/or cornea, to 
facilitate delivery of drugs into the eye. Similarly, micron-
eedles inserted into the eye can facilitate transport of fluid 
or as a subsequent step. In this way, microneedles would 
preferentially break at the site of the notch. Moreover, the 
size and shape of the portion of microneedles which break 
off can be controlled not only for specific drug release 
patterns, but also for specific interactions with cells in the 
body. For example, objects of a few microns in size are 
known to be taken up by macrophages. The portions of 
microneedles that break off can be controlled to be bigger or 
smaller than that to prevent uptake by macrophages or can 
be that size to promote uptake by macrophages, which can 
be desirable for delivery of vaccines. 
60 out of the eye, which may be of benefit for treatment of 
glaucoma. Microneedles may also be inserted into the buc-
cal (oral), nasal, vaginal, or other accessible mucosa to 
facilitate transport into, out of, or across those tissues. For 
example, a drug may be delivered across the buccal mucosa 
65 for local treatment in the mouth or for systemic uptake and 
delivery. As another example, microneedle devices may be 
used internally within the body on, for example, the lining 
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of the gastrointestinal tract to facilitate uptake of orally-
ingested drugs or the lining of blood vessels to facilitate 
penetration of drugs into the vessel wall. For example, 
cardiovascular applications include using microneedle 
devices to facilitate vessel distension or immobilization, 5 
similarly to a stent, wherein the microneedles/substrate can 
function as a "staple-like" device to penetrate into different 
tissue segments and hold their relative positions for a period 
of time to permit tissue regeneration. This application could 
be particularly useful with biodegradable devices. These 10 
uses may involve invasive procedures to introduce the 
microneedle devices into the body or could involve 
swallowing, inhaling, injecting or otherwise introducing the 
devices in a non-invasive or minimally-invasive manner. 
28 
photoresist) on the surface of the silicon wafer. The photo-
resist still present on the chromium dots formed the masks 
needed for fabrication of the micro needles, described below. 
The microneedles were fabricated using a reactive ion 
etching techniques based on the Black Silicon Method 
developed at the University ofTwente. The patterned wafers 
were etched in a reactive ion etcher (700 series wafer/batch 
Plasma Processing System, Plasma Therm, St. Petersburg, 
Fla.) with means for ensuring good thermal contact between 
the wafers and the underlying platen (Apiezon N, K. J. 
Lesker, Clairton, Pa.). The wafers were etched using the 
following gases and conditions: SF 6 (20 standard cubic 
centimeters per minute) and 0 2 (15 standard cubic centime-
ters per minute) at a pressure of 150 mTorr and a power of 
c. Delivery of Energy 15 150 W for a run time of approximately 250 minutes. These 
conditions caused both deep vertical etching and slight 
lateral underetching. By controlling the ratio of flow rates of 
the SF 6 and 0 2 gases used to form the plasma, the aspect 
Other than transport of drugs and biological molecules, 
the microneedles may be used to transmit or transfer other 
materials and energy forms, such as light, electricity, heat, or 
pressure. The microneedles, for example, could be used to 
direct light to specific locations within the body, in order that 20 
the light can directly act on a tissue or on an intermediary, 
such as light-sensitive molecules in photodynamic therapy. 
The present invention will be further understood with 
reference to the following non-limiting examples. 
EXAMPLE 1 
Fabrication of Solid Silicon Microneedles 
25 
A chromium masking material was deposited onto silicon 
wafers and patterned into dots having a diameter approxi- 30 
mately equal to the base of the desired microneedles. The 
wafers were then loaded into a reactive ion etcher and 
subjected to a carefully controlled plasma based on fluorine/ 
oxygen chemistries to etch very deep, high aspect ratio 
valleys into the silicon. Those regions protected by the metal 35 
mask remain and form the microneedles. 
<100>-oriented, prime grade, 450--550 µm thick, 10-15 
Q-cm silicon wafers (Nova Electronic Materials Inc., 
Richardson, Tex.) were used as the starting material. The 
wafers were cleaned in a solution of 5 parts by volume 40 
deionized water, 1 part 30% hydrogen peroxide, and 1 part 
30% ammonium hydroxide (J. T. Baker, Phillipsburg, N.J.) 
at approximately 80° C. for 15 minutes, and then dried in an 
oven (Blue M Electric, Watertown, Wis.) at 150° C. for 10 
minutes. Approximately 1000 A of chromium (Mat-Vac 45 
Technology, Flagler Beach, Fla.) was deposited onto the 
wafers using a DC-sputterer (601 Sputtering System, CVC 
Products, Rochester, N.Y.). The chromium layer was pat-
terned into 20 by 20 arrays of 80 µm diameter dots with 150 
µm center-to-center spacing using the lithographic process 50 
described below. 
ratio of the microneedles could be adjusted. The regions 
protected by the chromium masks remained and formed the 
microneedles. Etching was allowed to proceed until the 
masks fell off due to underetching, resulting in an array of 
sharp silicon spikes. 
EXAMPLE 2 
Transdermal Transport Using Solid Microneedles 
To determine if microfabricated microneedles could be 
used to enhance transdermal drug delivery, arrays of micron-
eedles were made using a deep plasma etching technique. 
Their ability to penetrate human skin without breaking was 
tested and the resulting changes in transdermal transport 
were measured. 
Arrays of microneedles were fabricated having extremely 
sharp tips (radius of curvature less than 1 µm), and are 
approximately 150 µm long. Because the skin surface is not 
fiat due to dermatoglyphics and hair, the full length of these 
microneedles will not penetrate the skin. All experiments 
were performed at room temperature (23±2° C.). 
The ability of the microneedles to pierce skin without 
breaking was then tested. Insertion of the arrays into skin 
required only gentle pushing. Inspection by light and elec-
tron microscopy showed that more than 95% of micron-
eedles within an array pierced across the stratum corneum of 
the epidermis samples. Moreover, essentially all of the 
microneedles that penetrated the epidermis remained intact. 
On those very few which broke, only the top 5-10 µm was 
damaged. Microneedle arrays could also be removed with-
out difficulty or additional damage, as well as re-inserted 
into skin multiple times. 
To quantitatively assess the ability of microneedles to 
increase transdermal transport, calcein permeability of 
human epidermis with and without inserted microneedle 
A layer of photosensitive material (1827 photoresist, 
Shipley, Marlborough, Mass.) was deposited onto the chro-
mium layer covering the silicon wafers. A standard litho-
graphic mask (Telic, Santa Monica, Calif.) bearing the 
appropriate dot array pattern was positioned on top of the 
photoresist layer. The wafer and photoresist were then 
exposed to ultraviolet (UV) light through the mask by means 
55 arrays was measured. Calcein crosses skin very poorly under 
normal circumstances and therefore represents an especially 
difficult compound to deliver. As expected, passive perme-
ability of calcein across unaltered skin was very low, indi-
of an optical mask aligner (Hybralign Series 500, Optical 
Associates, Inc., Milpitas, Calif.). The exposed photoresist 60 
was removed by soaking the wafers in a liquid developer 
(354 developer, Shipley, Marlborough, Mass.) leaving the 
desired dot array of photoresist on the chromium layer. 
Subsequently, the wafers were dipped into a chromium 
etchant (CR-75; Cyanteck Fremont, Calif.), which etched 65 
the chromium that had been exposed during the photolithog-
raphy step, leaving dot arrays of chromium (covered with 
cating that the epidermis samples were intact. 
Insertion of microneedles into skin was capable of dra-
matically increasing permeability to calcein. When micron-
eedles were inserted and left embedded in the skin, calcein 
permeability was increased by more than 1000-fold. Inser-
tion of microneedles for 10 s, followed by their removal, 
yielded an almost 10,000-fold increase. Finally, insertion of 
a microneedle array for 1 h, followed by its removal, 
increased skin permeability by about 25,000-fold. Perme-
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abilities for skin with microneedles inserted and then 
removed are higher than for skin with microneedles remain-
ing embedded probably because the microneedles them-
selves or the silicon plate supporting the array may block 
access to the microscopic holes created in the skin. Light 
microscopy showed that the holes which remained in the 
skin after microneedles were removed were approximately 1 
µmin size. 
To confirm in vitro experiments which showed that skin 
permeability can be significantly increased by microneedles, 
studies were conducted with human volunteers. They indi-
cated that microneedles could be easily inserted into the skin 
of the forearm or hand. Moreover, insertion of microneedle 
arrays was never reported to be painful, but sometimes 
elicited a mild "wearing" sensation described as a weak 
pressure or the feeling of a piece of tape affixed to the skin. 
Although transport experiments were not performed in vivo, 
skin electrical resistance was measured before and after 
microneedle insertion. Microneedles caused a 50-fold drop 
30 
the sacrificial layer. Arrays of cylindrical holes 49 were then 
photolithographically defined through an epoxy layer 44, 
typically 150 µm thick (FIG. Sa). The sacrificial layer then 
was partially removed using a wet etching solution contain-
s ing hydrofluoric acid and water at the bottom of the cylin-
drical holes in the SU-8 photoresist 46 (FIG. Sb). A seed 
layer of Ti/Cu/Ti (30 nm/200 nm/30 nm) 39 was then 
conformally DC sputter-deposited onto the upper surface of 
the epoxy mold and onto the sidewalls of the cylindrical 
10 
holes 49 (FIG. Sc). As shown in FIG. Sc, the seed layer 39 
was electrically isolated from the substrate. Subsequently, 
NiFe was electroplated onto the seed layer 39 (FIG. Sd), the 
epoxy 44 was removed from the substrate, and the surround-
ing epoxy 44 was removed (FIG. Se). The resulting micro-
tubes are 200 µm in height with an outer diameter of 80 µm, 
15 an inner diameter of 60 µm, and a tube center-to-center 
spacing of 150 µm. The holes in the interior of the micro-
tubes protrude through the base metal supporting the tubes. 
EXAMPLE 5 
in skin resistance, a drop similar to that caused by the 20 
insertion of a 30-gauge "macroneedle." Inspection of the site 
immediately after microneedle insertion showed no holes 
visible by light microscopy. No erythema, edema, or other 
reaction to microneedles was observed over the hours and 
days which followed. This indicates that microneedle arrays 25 
can permeabilize skin in human subjects in a non-painful 
and safe manner. 
Micromold Fabrication of Tapered Microneedles 
A micromold having tapered walls was fabricated by 
molding a preexisting 3-D array of microneedles, i.e. the 
mold-insert, and subsequently removing the mold insert. 
The micromold was then surface plated in a manner similar 
to that for the microtubes described in Example 4. The 
fabrication sequence is illustrated in FIGS. 6a-d. 
First, an array of solid silicon microneedles SO were 
prepared as described in Henry, et al., "Micromachined 
Needles for the Transdermal Delivery of Drugs," Micro EXAMPLE 3 
Fabrication of Silicon Microtubes 
Three-dimensional arrays of microtubes were fabricated 
from silicon, using deep reactive ion etching combined with 
a modified black silicon process in a conventional reactive 
ion etcher. The fabrication process is illustrated in FIGS. 
4a-d. First, arrays of 40 µm diameter circular holes 32 were 
patterned through photoresist 34 into a 1 µm thick Si02 layer 
30 Electro Mechanical Systems, Heidelberg, Germany, pp. 
494-98, Jan. 26-29 (1998). Then, a layer of epoxy S2 
(SU-8) was spin cast onto the microneedle array to com-
pletely blanket the array (FIG. 6a). The epoxy S2 settled 
during pre-bake to create a planar surface above the tips of 
35 
the microneedles SO. The epoxy S2 was then fully pre-baked, 
photolithographically cross-linked, and post-baked. 
Then, the upper surface of the epoxy S2 was etched away 
using an 0 2/CHF3 plasma until approximately 1 to 2 µm of 
the needle tips S4 were exposed, protruding from the epoxy 
40 S2 (FIG. 6b). The silicon was then selectively removed by 
using a SF6 plasma (FIG. 6c). The remaining epoxy mold S2 
provided a negative of the microneedles with a small diam-
eter hole where the tip of the silicon needle protruded. After 
the removal of the silicon, a seed layer of Ti-Cu-Ti S4 
36 on a two inch silicon wafer 38 (FIG. 4a). The wafer 38 
was then etched using deep reactive ion etching (DRIE) 
(Laermer, et al., "Bosch Deep Silicon Etching: Improving 
Uniformity and Etch Rate for Advanced MEMS 
Applications," Micro Electro Mechanical Systems, Orlando, 
Fla., USA (Jan. 17-21, 1999)), in an inductively coupled 
plasma (ICP) reactor to etch deep vertical holes 40. The deep 
silicon etch was stopped after the holes 40 are approximately 
200 µm deep into the silicon substrate 38 (FIG. 4b) and the 
photoresist 34 was removed. A second photolithography step 
patterned the remaining Si02 layer 36b into circles concen-
tric to the holes, thus leaving ring shaped oxide masks 
surrounding the holes (FIG. 4c). The photoresist 34b was 
then removed and the wafer 38 was again deep silicon 
etched, while simultaneously the holes 40 were etched 
completely through the wafer 38 (inside the Si02 ring) and 
the silicon was etched around the Si02 ring 38 leaving a 55 
cylinder 42 (FIG. 4d). The resulting tubes were 150 µm in 
height, with an outer diameter of 80 µm, an inner diameter 
of 40 µm, and a tube center-to-center spacing of 300 µm. 
EXAMPLE 4 
Micromold Fabrication of Metal Microtubes 
45 was conformally sputter-deposited onto the top and side-
walls of the epoxy micromold S2. Following the same 
process sequence as described in Example 4, NiFe was then 
electroplated onto the seed layer S4 (FIG. 6c). Finally, the 
epoxy was removed using an 0 2/CHF3 plasma, leaving a 
50 20x20 array of NiFe hollow metal microneedles S4 (FIG. 
6d). The microneedles S4 were 150 µmin height with a base 
diameter of 80 µm, a tip diameter of 10 µm, and a needle-
to-needle spacing of 150 µm. 
Micromold-based microneedles also have been success-
fully manufactured using a process in which the epoxy mold 
material was replaced with PDMS. In this case, it was 
possible to remove the mold from the mold insert, as well as 
the microneedles from the mold, using only physical tech-
niques such as peeling. This approach advantageously 
60 requires no dry etching and allows one to reuse both the 
mold and the mold insert. 
EXAMPLE 6 
Hollow metal microtubes were prepared without dry 
silicon etching, using a thick, photo-defined mold of epoxy. 
The sequences are illustrated in FIGS. Sa-e. First, a thick 65 
layer of SU-8 epoxy 44 was spin cast onto a silicon or glass 
substrate 46 that had been coated with 30 nm of titanium 48, 
Micromold Fabrication of Tapered Microneedles 
Using Laser-Formed Molds 
A micromold having tapered walls was fabricated by use 
of laser ablation techniques, as shown in FIGS. 7a-d. A 
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laser-ablatable polymer sheet 60 such as KAPTON™ poly-
imide approximately 150 microns in thickness was option-
ally laminated to a thin (10-30 micron) metal sheet 62 such 
as titanium (FIG. 7a). A tapered hole 64 was formed in the 
metal/polymer laminate 60/62 using a laser technique such 5 
as excimer laser ablation (FIG. 7b). The entry hole of the 
laser spot was on the metal side 62, and a through hole was 
made through both the metal sheet and the polymer film. The 
through hole 64 was tapered in combination with either 
defocusing or appropriate substrate motion to create a taper 10 
such that the wide end of the hole 64 (typically 40-50 
microns) was on the metal side 62 and the narrow end of the 
hole 64 (typically 10-20 microns) was on the polymer 60 
side. A thin layer of metal 66, e.g. titanium, of thickness 0.1 
micron was then deposited, e.g., using a sputter-deposition 15 
technique, in such a way that the metal 66 deposited on the 
metal film side and coated the polymer sidewalls, but did not 
coat the polymer 60 side of the laminate (FIG. 7c). Elec-
trodeposition of metal 6S, e.g., gold, to a thickness of 1 to 
5 microns was then performed on the titanium-coated metal 20 
surface 66, and polymer sidewalls curved section of 60 next 
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shown in Table 1, transport of a number of different com-
pounds across skin is possible using microneedles. These 
studies were performed using either solid silicon micron-
eedles or using hollow silicon microneedles made by meth-
ods described in this patent. Transport was measured across 
human cadaver epidermis in vitro using Franz diffusion 
chambers at 37° C. using methods described in Henry, et al., 
"Micro fabricated micro needles: A novel method to increase 
transdermal drug delivery" J. Pharm. Sci. 87: 922-25 
(1998). 
The transdermal delivery of calcein, insulin, bovine serum 
albumin ("BSA"), and nanoparticles was measured. Deliv-
ery refers to the ability to transport these compounds from 
the stratum corneum side of the epidermis to the viable 
epidermis side. This is the direction of transport associated 
with delivering drugs into the body. Removal of calcein was 
also measured. Removal refers to the ability to transport 
calcein from the viable epidermis side of the epidermis to the 
stratum corneum side. This is the direction of transport 
associated with removing from the body compounds found 
in the body, such as glucose. 
to 64. Finally, the polymer 60 was removed, using e.g. an 
oxygen plasma, to form the completed microneedles (FIG. 
7d). 
Alternate polymer removal methods, such as thermal, 
solvent, aqueous, or photo-degradation followed by solvent 
In all cases shown in Table 1, transport of these com-
pounds across skin occurred at levels below the detection 
25 limit when no needles were inserted into the skin. Intact skin 
or aqueous removal, are also possible if the polymer material 
is chosen appropriately (e.g., a photoresist resin). 
EXAMPLE 7 
Formation of Microneedles by Embossing 
Formation of a microneedle by embossing is shown in 
FIGS. Sa-f. A polymeric layer 70 (FIG. Sa) is embossed by 
a solid microneedle or microneedle array 72 (FIG. Sb). The 
array 72 is removed (FIG. Sc), and the layer 70 is etched 
from the non-embossed side 74 until the embossed cavity 76 
is exposed (FIG. Sd.). A metallic layer 7S is then deposited 
on the embossed side and the sidewalls, but not on the 
non-embossed side 74 (FIG. Se). This layer 7S is optionally 
thickened by electrodeposition of an additional metal layer 
SO on top of it (FIG. Se). The polymer layer 70 is then 
removed to form the microneedles 7S/SO (FIG. Sf). 
EXAMPLE 8 
Transdermal Application of Hollow Microneedles 
provides an excellent barrier to transport of these com-
pounds. In all cases examined, when solid microneedles 
were inserted into the skin and left in place, large skin 
permeabilities were measured, indicating that the micron-
30 eedles had created pathways for transport across the skin. 
Furthermore, in all cases, when solid microneedles were 
inserted into the skin and then removed, even greater skin 
permeabilities resulted. Finally, when hollow microneedles 
were inserted into the skin and left in place, still greater skin 
35 permeabilities resulted for those compounds tested. These 
studies show that microneedles can dramatically increase 
skin permeability and can thereby increase transport of a 
number of different compounds across the skin. They also 
shows that when solid microneedles are used, a preferred 
40 embodiment involves inserting and then removing 
microneedles, rather than leaving them in place. They also 
shows that using hollow microneedles are a preferred 
embodiment over the use of solid microneedles. 
In Table 2, the flow rate of water through hollow silicon 
45 microneedles is shown as a function of applied pressure. 
The bore of hollow microneedles must provide fluid flow 
with minimal clogging in order to be suitable to transport 
material, such as in transdermal drug delivery. Therefore, 
microneedles and microtubes were evaluated to determine 50 
their suitability for these functions. 
These data demonstrate that significant flow rates of water 
through microneedles can be achieved at modest pressures. 
TABLE 1 
Transport of Drugs Through Microneedles Inserted Into Skin 
Hollow metal and silicon microneedles, produced as 
described in Examples 3-5, were inserted through human 
skin epidermis with no apparent clogging of the needle 
bores. Scanning electron microscopy of a hollow metal 
(NiFe) microneedle penetrating up through the underside of 
human epidermis showed the microneedle remains intact, 
with the tip free of debris. Similarly, silicon microneedles, 
metal microneedles, and metal microtubes were successfully 
inserted through human skin. Also, the hollow microneedles 





No Solid needles inserted and 
Compound needles inserted removed 
Calcein 4 x 10-3 1 x 10-2 
delivery 
Calcein 2 x 10-3 1 x 10-2 
removal 
Insulin 1 x 10-4 1 x 10-2 
delivery 
BSA delivery 9 x 10-4 8 x 10-3 
Nanoparticle n.a. 3 x 10-5 
delivery 
* * means that the transport was below the detection limit. 




1 x 10-1 
n.a. 
n.a. 
9 x 10-2 
n.a. 
Drug Transport Through Microneedles Inserted Into 
Skin 65 Nanoparticles were made of latex with a diameter of approximately 100 
Studies were performed with solid and hollow micron- nm. 
eedles to demonstrate transport of molecules and fluids. As 
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TABLE 2 
Flow Rate of Water Through Hollow Silicon Microneedles 
as a Function of Applied Pressure 
Pressure (psi) Flow rate (ml/min) 
9. The device of claim 8 wherein the body portion 
comprises an annular ring which holds the microneedles. 
10. The device of claim 9 wherein the microneedle is 
hollow and wherein the body portion further comprises a 
5 means for attachment to a syringe, a conduit for connection 




2.5 38 10 
3.0 45 
Publications cited herein and the material for which they 
are cited are specifically incorporated by reference. Nothing 
herein is to be construed as an admission that the invention 15 
is not entitled to antedate such disclosure by virtue of prior 
invention. 
Modifications and variations of the methods and devices 
described herein will be obvious to those skilled in the art 
20 
from the foregoing detailed description. Such modifications 
and variations are intended to come within the scope of the 
appended claims. 
We claim: 
1. A device for transport of material or energy across or 
25 
into an elastic biological barrier comprising 
a microneedle having a tip end and a base end, 
a substrate connected to the base end of the microneedle, 
and 
a means for securing the biological barrier in place for 30 
insertion of the microneedle, 
wherein the means reduces the elasticity of the biological 
barrier, thereby improving penetration of the biological 
barrier by the microneedle. 
2. The device of claim 1 wherein the biological barrier is 35 
human or other mammalian skin. 
3. The device of claim 1 comprising a plurality of 
microneedles of varying lengths. 
4. The device of claim 3 comprising four or more micron-
eedles wherein the tip ends of the microneedles collectively 40 
define a curvilinear surface. 
5. The device of claim 1 wherein the means physically 
manipulates the biological barrier to present a more rigid 
surface in the area of the biological barrier to be penetrated 
by the microneedle. 45 
6. The device of claim 5 wherein the manipulation is 
selected from the group consisting of stretching, pulling, 
pinching, and a combination thereof. 
7. The device of claim 6 wherein the manipulation 
includes pulling by reducing the atmospheric pressure over 50 
the area of the biological barrier to be penetrated by the 
microneedles. 
8. The device of claim 7 further comprising a body portion 
defining a first vacuum region and a second vacuum region, 
wherein an array of microneedles separates the first and 55 
second regions. 
11. The device of claim 6 wherein the means comprises a 
stretching cone or expandable ring around the microneedles. 
12. The device of claim 1, wherein the means comprises 
an apparatus for vibrating the microneedle. 
13. The device of claim 12, wherein the apparatus com-
prises a piezoelectric transducer or an electromechanical 
actuator. 
14. A device for transport of material or energy across or 
into an elastic biological barrier comprising 
a microneedle having a tip end and a base end, 
a substrate connected to the base end of the microneedle, 
a means for securing the biological barrier in place for 
insertion of the microneedle, and 
a plurality of hollow microneedles in a linear array, 
wherein the substrate is mounted on a holder having 
one or more apertures through the holder in commu-
nication with the microneedles, 
thereby improving penetration of the biological barrier by 
the microneedle. 
15. A device for transport of material or energy across or 
into an elastic biological barrier comprising 
a microneedle having a tip end and a base end, 
a substrate connected to the base end of the microneedle, 
and 
a means for securing the biological barrier in place for 
insertion of the microneedle, 
wherein the means for securing the biological barrier in 
place accelerates the tip of the microneedle into the 
biological barrier, 
accelerates the biological barrier into contact with the tip 
of the microneedle, or a combination thereof, 
thereby improving penetration of the biological barrier by 
the microneedle. 
16. The device of claim 15 wherein the means for 
accelerating the tip of the microneedle comprises a spring or 
gas under compression. 
17. The device of claim 14 or 6, wherein the means 
comprises a body portion from which a plurality of stretch-
ing elements are pivotally attached. 
18. The device of claim 17 herein the stretching elements 
have ends provided with a nonslip feature for engagement 
with the biological barrier. 
19. The device of claim 14 or 6, wherein the means 
comprises jaws for pinching a portion of the biological 
barrier for contact with the microneedle. 
* * * * * 
